Antibody	Immunogenicity	Species	Reference	VH	VL	T20	Z-score	IgReconstruct	AbLSTM	Germline content	Hu-mAb	MG Score	"Non-human MHCII binders
(predicted NetMHCIIpan 3.1, OASis loose)"	"Non-human MHCII binders
(predicted NetMHCIIpan 3.1, OASis relaxed)"	"Non-human MHCII binders
(predicted NetMHCIIpan 3.1, OASis medium)"	"Non-human MHCII binders
(predicted NetMHCIIpan 3.1, OASis strict)"	OASis identity (loose)	OASis identity (relaxed)	OASis identity (medium)	OASis identity (strict)	OASis percentile (loose)	OASis percentile (relaxed)	OASis percentile (medium)	OASis percentile (strict)
3F8	100.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLKESGPGLVAPSQSLSITCTVSGFSVTNYGVHWVRQPPGKGLEWLGVIWAGGITNYNSAFMSRLSISKDNSKSQVFLKMNSLQIDDTAMYYCASRGGHYGYALDYWGQGTSVTVSS	SIVMTQTPKFLLVSAGDRVTITCKASQSVSNDVTWYQQKAGQSPKLLIYSASNRYSGVPDRFTGSGYGTAFTFTISTVQAEDLAVYFCQQDYSSFGGGTKLEIK	74.17902000000001	-1.3485	-3.815430346852995	1.2729849	0.6342517776341305	0.01	5079.047839738183	22	30	31	32	0.6811594202898552	0.4975845410628021	0.2898550724637681	0.2028985507246377	0.05026210299105763	0.038150546476170916	0.04072874910062696	0.037747969986637805
Abagovomab	68.1	Mouse	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221001/	QVKLQESGAELARPGASVKLSCKASGYTFTNYWMQWVKQRPGQGLDWIGAIYPGDGNTRYTHKFKGKATLTADKSSSTAYMQLSSLASEDSGVYYCARGEGNYAWFAYWGQGTTVTVSS	DIELTQSPASLSASVGETVTITCQASENIYSYLAWHQQKQGKSPQLLVYNAKTLAGGVSSRFSGSGSGTHFSLKIKSLQPEDFGIYYCQHHYGILPTFGGGTKLEIK	67.55306999999999	-1.6235	-2.9927795736384377	1.304958	0.6693238042880704	0.025	5303.898979925327	16	21	24	24	0.6333333333333334	0.4333333333333333	0.2333333333333334	0.1904761904761905	0.02659574468085105	0.008274231678486916	0.015366430260047253	0.03047956771361028
Abciximab	35.5	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLQQSGAELVKPGASVKLSCTASGFNIKDTYVHWVKQRPEQGLEWIGRIDPANGYTKYDPKFQGKATITADTSSNTAYLQLSSLTSEDTAVYYCVRPLYDYYAMDYWGQGTSVTVSS	DILMTQSPSSMSVSLGDTVSITCHASQGISSNIGWLQQKPGKSFMGLIYYGTNLVDGVPSRFSGSGSGADYSLTISSLDSEDFADYYCVQYAQLPYTFGGGTKLEIK	66.04927	-1.5379999999999998	-3.8682089285207057	1.2660764	0.6562475457472708	0.0125	5046.512770549584	13	19	24	25	0.5952380952380953	0.4285714285714287	0.2095238095238096	0.180952380952381	0.0054035798716649455	0.006585612968591654	0.008611955420466043	0.025329280648429535
Abrilumab	0.4	Human	https://www.gastrojournal.org/article/S0016-5085(18)35283-1/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F	QVQLVQSGAEVKKPGASVKVSCKVSGYTLSDLSIHWVRQAPGKGLEWMGGFDPQDGETIYAQKFQGRVTMTEDTSTDTAYMELSSLKSEDTAVYYCATGSSSSWFDPWGQGTLVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFANYYCQQANSFPWTFGQGTKVEIK	90.070785	0.133	0.8303707589093914	0.2721308	0.9295897354664977	0.998	9019.816661061188	0	0	3	3	0.99043062200957	0.9856459330143547	0.8755980861244022	0.8564593301435408	0.9694594319454362	0.9857307679256174	0.8009179137398629	0.8866011741151724
Actoxumab	0.0	Human	"MK-3415 no ADA present
https://www.tga.gov.au/sites/default/files/auspar-bezlotoxumab-180924-cer.pdf"	QVQLVESGGGVVQPGRSLRLSCAASGFSFSNYGMHWVRQAPGKGLEWVALIWYDGSNEDYTDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARWGMVRGVIDVFDIWGQGTVVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQHKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPWTFGQGTKVEIK	91.92152	1.0095	0.06810200432875596	0.44425675	0.9204075379194117	1.0	9439.730055294314	0	2	4	5	0.9765258215962435	0.9248826291079806	0.8920187793427226	0.8685446009389669	0.894957213731557	0.7975393733559732	0.8543185828921507	0.9059950720873704
Adalimumab	14.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK	90.18737	0.879	0.47645625941809266	0.43690428	0.9011740171468294	0.9995	9325.819358935509	6	7	10	11	0.9481132075471708	0.8962264150943403	0.8396226415094341	0.8254716981132075	0.7597015923993081	0.7304630001338162	0.7474909674829389	0.8211227084169678
Aducanumab	5.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651340/	QVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPLTFGGGTKVEIK	93.99257	1.1480000000000001	0.7403941479971314	0.38181826	0.9221058185107024	1.0	9824.481552499632	0	1	2	2	0.9581395348837206	0.9441860465116276	0.8883720930232557	0.8790697674418604	0.799480455220187	0.8607537522678531	0.8414563747319808	0.9238825663862774
Afutuzumab	6.6	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125486s017s018lbl.pdf	QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS	DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK	83.72772	-0.8945000000000001	-1.6395015037414886	0.78536236	0.8321953781512605	0.696	7068.220793317324	10	15	19	23	0.7674418604651161	0.7069767441860463	0.6511627906976744	0.627906976744186	0.15540986310407348	0.2167656275771064	0.3349414481279888	0.4737341250206167
Alemtuzumab	5.1	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQESGPGLVRPSQTLSLTCTVSGFTFTDFYMNWVRQPPGRGLEWIGFIRDKAKGYTTEYNPSVKGRVTMLVDTSKNQFSLRLSSVTAADTAVYYCAREGHTAAPFDYWGQGSLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK	78.961085	-0.3095	-1.6320623463048278	0.8534309	0.785278442882521	0.8385	6816.212472030607	8	11	16	19	0.8443396226415107	0.7735849056603785	0.6367924528301891	0.5849056603773586	0.4613608992372569	0.46647932557206306	0.28927472233373575	0.31623845845042176
Alirocumab	3.9	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125559s019s020lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFTFNNYAMNWVRQAPGKGLDWVSTISGSGGTTNYADSVKGRFIISRDSSKHTLYLQMNSLRAEDTAVYYCAKDSNWGNFDLWGRGTLVTVSS	DIVMTQSPDSLAVSLGERATINCKSSQSVLYRSNNRNFLGWYQQKPGQPPNLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYTTPYTFGQGTKLEIK	89.45036999999999	0.40549999999999997	-0.16946385999035274	0.44676167	0.8968051597420129	1.0	8845.943563009485	0	3	7	9	0.9767441860465109	0.934883720930232	0.8511627906976741	0.7534883720930232	0.8965446148771187	0.8267771730166568	0.7671944581890151	0.7087662873165099
Amatuximab	29.2	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057907/	QVQLQQSGPELEKPGASVKISCKASGYSFTGYTMNWVKQSHGKSLEWIGLITPYNGASSYNQKFRGKATLTVDKSSSTAYMDLLSLTSEDSAVYFCARGGYDGRGFDYWGSGTPVTVSS	DIELTQSPAIMSASPGEKVTMTCSASSSVSYMHWYQQKSGTSPKRWIYDTSKLASGVPGRFSGSGSGNSYSLTISSVEAEDDATYYCQQWSKHPLTFGSGTKVEIK	64.80062000000001	-1.9905	-3.59651286155201	1.2953972	0.6358807674013001	0.0195	4881.909469265862	10	15	18	19	0.5215311004784688	0.3205741626794258	0.1770334928229665	0.1196172248803828	0.0035460992907801	0.0018748515389052113	0.0030201228409514557	0.006956462723539918
Andecaliximab	21.2	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113706/	QVQLQESGPGLVKPSETLSLTCTVSGFSLLSYGVHWVRQPPGKGLEWLGVIWTGGTTNYNSALMSRFTISKDDSKNTVYLKMNSLKTEDTAIYYCARYYYGMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVRNTVAWYQQKPGKAPKLLIYSSSYRNTGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQHYITPYTFGGGTKVEIK	91.029685	0.0165	-3.1242635082192893	0.7467815	0.7537180008126778	0.425	6744.077808262073	7	12	16	19	0.8446601941747571	0.7378640776699028	0.6213592233009708	0.5679611650485437	0.46204296632927033	0.3385664118983674	0.2579701163671416	0.2768539557942573
Anifrolumab	3.3	Human	https://ard.bmj.com/content/76/Suppl_2/870.2	EVQLVQSGAEVKKPGESLKISCKGSGYIFTNYWIAWVRQMPGKGLESMGIIYPGDSDIRYSPSFQGQVTISADKSITTAYLQWSSLKASDTAMYYCARHDIEGFDYWGRGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSFFAWYQQKPGQAPRLLIYGASSRATGIPDRLSGSGSGTDFTLTITRLEPEDFAVYYCQQYDSSAITFGQGTRLEIK	91.03997	-0.10500000000000001	0.5876325565290077	0.39926654	0.9163105413105413	1.0	9094.82768529679	0	0	2	10	0.9760765550239241	0.9377990430622016	0.8899521531100483	0.7942583732057417	0.8916912687909372	0.8355644914995438	0.847339577182804	0.7678916827852997
Arcitumomab	0.5	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVKLVESGGGLVQPGGSLRLSCATSGFTFTDYYMNWVRQPPGKALEWLGFIGNKANGYTTEYSASVKGRFTISRDKSQSILYLQMNTLRAEDSATYYCTRDRGLRFYFDYWGQGTTLTVSS	QTVLSQSPAILSASPGEKVTMTCRASSSVTYIHWYQQKPGSSPKSWIYATSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQHWSSKPPTFGGGTKLEIK	69.73222	-1.0665	-2.846324425537338	0.81382805	0.7091844690472477	0.0	5382.051286845273	8	14	23	24	0.7677725118483414	0.5924170616113744	0.3744075829383885	0.3080568720379147	0.1564065073442915	0.08773654667070009	0.07524957144297661	0.08550132768646428
Atezolizumab	28.9	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK	89.819135	1.1305	-0.7445106604045312	0.6053434	0.8493980674798036	0.958	8231.242041270372	6	10	13	16	0.8708133971291875	0.7990430622009577	0.6842105263157897	0.645933014354067	0.5308205232617353	0.526163086633413	0.4605263157894744	0.5264175913671995
Avelumab	5.0	Human	https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0586-0/tables/2	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYIMMWVRQAPGKGLEWVSSIYPSGGITFYADTVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARIKLGTVTTVDYWGQGTLVTVSS	QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCSSYTSSSTRVFGTGTKVTVL	90.82972000000001	1.242	0.3842313419031177	0.5266805	0.9068181818181817	0.9975	9345.72322935094	4	9	12	14	0.9205607476635507	0.873831775700934	0.8504672897196258	0.8364485981308409	0.6699310664810746	0.6775369523430751	0.7664545635315169	0.8475674421687541
Basiliximab	1.5	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIGAIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYCSRDYGYYFDFWGQGTTLTVSS	QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYTFGGGTKLEIK	78.07167	-1.9535	-3.5594828671316456	1.3345908	0.6655982905982907	0.0025	4787.585790494157	14	18	23	23	0.6097560975609758	0.3902439024390246	0.2536585365853659	0.1658536585365854	0.008822003113648141	0.0035460992907801	0.02144957619788958	0.02084414461165889
Bavituximab	58.0	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLQQSGPELEKPGASVKLSCKASGYSFTGYNMNWVKQSHGKSLEWIGHIDPYYGDTSYNQKFRGKATLTVDKSSSTAYMQLKSLTSEDSAVYYCVKGGYYGHWYFDVWGAGTTVTVSS	DIQMTQSPSSLSASLGERVSLTCRASQDIGSSLNWLQQGPDGTIKRLIYATSSLDSGVPKRFSGSRSGSDYSLTISSLESEDFVDYYCLQYVSSPPTFGAGTKLELK	65.942935	-1.772	-3.60285698688438	1.3750609	0.6582943925233644	0.0	4848.874339269412	9	14	19	23	0.62085308056872	0.4218009478672983	0.1990521327014217	0.1232227488151659	0.02157910658465243	0.00418473328627595	0.0035460992907801	0.0070921985815602
Begelomab	28.0	Mouse	https://www.ema.europa.eu/en/documents/withdrawal-report/withdrawal-assessment-report-begedina_en.pdf	QVQLQQSGAELVKPGASVKLSCKASGYTFRSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCARWTVVGPGYFDVWGAGTTVTVSS	QIVLTQSPAIMSASPGEKVTITCSASSSVSYMNWFQQKPGTSPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISRMEAEDAATYYCQQRSSYPNTFGGGTKLEIK	67.81997	-1.317	-2.927638607069272	1.1364555	0.6682389937106918	0.0	5382.600454594933	6	12	19	20	0.7095238095238096	0.480952380952381	0.2095238095238096	0.1476190476190476	0.0652651131374535	0.03225261735900029	0.008611955420466043	0.011567038162782747
Belimumab	2.4	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761043lbl.pdf	QVQLQQSGAEVKKPGSSVRVSCKASGGTFNNNAINWVRQAPGQGLEWMGGIIPMFGTAKYSQNFQGRVAITADESTGTASMELSSLRSEDTAVYYCARSRDLLLFPHHALSPWGRGTMVTVSS	SSELTQDPAVSVALGQTVRVTCQGDSLRSYYASWYQQKPGQAPVLVIYGKNNRPSGIPDRFSGSSSGNTASLTITGAQAEDEADYYCSSRDSSGNHWVFGGGTELTVL	87.35407000000001	-0.44499999999999995	-0.34091281362982906	0.8013435	0.8624661246612466	0.9824999999999999	7263.75091129087	5	6	8	11	0.920930232558139	0.87906976744186	0.7627906976744184	0.7395348837209301	0.6709137390730648	0.6923965033811635	0.6262163945241624	0.6941283193138708
Benralizumab	13.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf	EVQLVQSGAEVKKPGASVKVSCKASGYTFTSYVIHWVRQRPGQGLAWMGYINPYNDGTKYNERFKGKVTITSDRSTSTVYMELSSLRSEDTAVYLCGREGIRYYGLLGDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCGTSEDIINYLNWYQQKPGKAPKLLIYHTSRLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGYTLPYTFGQGTKVEIK	81.68037000000001	-0.2895	-1.023586179592812	0.8864719	0.8064802656986174	0.7955	7085.852664071418	4	12	15	16	0.8018867924528317	0.7075471698113219	0.5896226415094343	0.5518867924528302	0.2512712431419844	0.21868727418707729	0.1947009233239666	0.24702261474642045
Berlimatoxumab	0.0	Human	https://www.ema.europa.eu/en/documents/assessment-report/zinplava-epar-public-assessment-report_en.pdf	ELQLQESGPGLVKPSETLSLTCTVSGGSISSGSYYWDWIRQPPGKGLEWIGNIYKSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARERGMHYMDVWGKGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSINSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQQFDPPFTFGGGTKVEIK	91.22957	0.4099999999999999	0.0628010784903675	0.41070288	0.9084661902144036	0.9215	9363.548018561249	0	1	2	2	0.9238095238095235	0.9047619047619045	0.8380952380952381	0.8285714285714286	0.6785714285714278	0.7543904086457269	0.7445119891928402	0.8282674772036475
Bevacizumab	0.3	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK	81.45546999999999	0.626	-1.356996877447239	0.8670985	0.8057138515310387	0.8545	7442.760490987624	11	14	18	18	0.8457943925233631	0.7523364485981296	0.6495327102803733	0.6214953271028034	0.46445615430502796	0.38559687147875	0.32821303108636407	0.4475873268376734
Bezlotoxumab	0.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf	EVQLVQSGAEVKKSGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIFYPGDSSTRYSPSFQGQVTISADKSVNTAYLQWSSLKASDTAMYYCARRRNWGNAFDIWGQGTMVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSTWTFGQGTKVEIK	94.30521999999999	0.414	0.8151738244756226	0.39196315	0.9445222533457829	1.0	10216.163134595818	0	0	3	3	0.9857819905213275	0.9573459715639815	0.8720379146919433	0.8720379146919433	0.9478925078148662	0.9164817989311305	0.7933430809048438	0.9114147423616017
Bimekizumab	12.8	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401985/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSDYNMAWVRQAPGKGLEWVATITYEGRNTYYRDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASPPQYYEGSIYRLWFAHWGQGTLVTVSS	AIQLTQSPSSLSASVGDRVTITCRADESVRTLMHWYQQKPGKAPKLLIYLVSNSEIGVPDRFSGSGSGTDFRLTISSLQPEDFATYYCQQTWSDPWTFGQGTKVEIK	79.535785	0.3665	-1.7876329803567166	0.6847373	0.8025420560747664	0.8775	6692.631168336209	12	14	21	22	0.7685185185185192	0.708333333333334	0.6203703703703707	0.5787037037037038	0.15865510900972093	0.22133569739952935	0.25604150249540375	0.30043341213554
Birtamimab	0.0	Humanized/Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470113/	EVQLVESGGGLVQPGGSLRLSCAASGFTFNTYAMYWIRQAPGKGLEWVARIRSKSNNYAIYYADSVKDRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARPYSDSFAYWGQGTLVTVSS	DVVMTQSPLSLPVTPGEPASISCRSSQSLVHSTGNTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPFTFGGGTKVEIK	83.51632000000001	-0.3595	-1.3639281860587156	0.5761296	0.8405987394957983	0.6825	7455.326983389709	1	5	15	21	0.9116279069767437	0.851162790697674	0.7348837209302324	0.7023255813953487	0.6432046841497593	0.6306696354939795	0.5759112650503044	0.6327313211281542
Bleselumab	2.2	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972670/#ajt15560-sup-0005	QLQLQESGPGLLKPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCTRPVVRYFGWFDPWGQGTLVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPTFGQGTKVEIK	94.3228	0.31099999999999994	0.23104080526060944	0.53314316	0.9232808358022766	1.0	8737.724114015433	3	5	6	7	0.9526066350710907	0.9146919431279625	0.8530805687203792	0.8341232227488151	0.77789822190851	0.778982219085073	0.7692346475748716	0.8417952337736547
Blinatumomab	1.4	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSGAELVRPGSSVKISCKASGYAFSSYWMNWVKQRPGQGLEWIGQIWPGDGDTNYNGKFKGKATLTADESSSTAYMQLSSLASEDSAVYFCARRETTTVGRYYYAMDYWGQGTTVTVSS	DIQLTQSPASLAVSLGQRATISCKASQSVDYDGDSYLNWYQQIPGQPPKLLIYDASNLVSGIPPRFSGSGSGTDFTLNIHPVEKVDAATYHCQQSTEDPWTFGGGTKLEIK	67.48517	-1.2355	-3.9960645433948017	1.5261755	0.6855565242662016	0.05599999999999995	5231.239160200975	7	14	18	19	0.6073059360730593	0.4794520547945205	0.3424657534246575	0.2602739726027397	0.008387577317918248	0.031137666375206298	0.05229282036335369	0.0640240940444962
Bococizumab	25.5	Humanized	https://www.ncbi.nlm.nih.gov/pubmed/31529318	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGEISPFGGRTNYNEKFKSRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARERPLYASDLWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQRYSLWRTFGQGTKLEIK	86.308535	0.2535	-0.31758967392865345	0.5926957	0.8625455409472518	0.8855	8085.864355479286	6	8	15	15	0.8421052631578951	0.8038277511961726	0.7464114832535886	0.736842105263158	0.4566069428891384	0.5371916250975607	0.6017934100240935	0.6888764464352373
Brazikumab	2.5	Human	https://www.gastrojournal.org/article/S0016-5085(17)35401-X/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNEYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGYTSSWYPDAFDIWGQGTMVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSSSNTGAGYDVHWYQQVPGTAPKLLIYGSGNRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTRLTVL	92.672685	1.2690000000000001	0.9585799333110447	0.21217167	0.9196091252542866	1.0	9773.16732819838	0	0	1	2	0.9863013698630134	0.963470319634703	0.91324200913242	0.9041095890410958	0.9503788982803832	0.9353039282360177	0.9070808640176172	0.9497231127951034
Brentuximab	35.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QIQLQQSGPEVVKPGASVKISCKASGYTFTDYYITWVKQKPGQGLEWIGWIYPGSGNTKYNEKFKGKATLTVDTSSSTAFMQLSSLTSEDTAVYFCANYGNYWFAYWGQGTQVTVSA	DIVLTQSPASLAVSLGQRATISCKASQSVDFDGDSYMNWYQQKPGQPPKVLIYAASNLESGIPARFSGSGSGTDFTLNIHPVEEEDAATYYCQQSNEDPWTFGGGTKLEIK	69.34287	-1.2095	-3.029639352875911	1.2707337	0.7067452067452067	0.0	5408.1697007862695	5	9	12	16	0.64622641509434	0.5283018867924529	0.3962264150943396	0.3349056603773585	0.031245818279138256	0.06319416566305382	0.08199518265756722	0.09393817743877961
Brodalumab	3.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761032lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKASGYTFTRYGISWVRQAPGQGLEWMGWISTYSGNTNYAQKLQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARRQLYFDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSVSSNLAWFQQKPGQAPRPLIYDASTRATGVPARFSGSGSGTDFTLTISSLQSEDFAVYYCQQYDNWPLTFGGGTKVEIK	96.029685	0.3335	0.574109350619159	0.27394158	0.9367547534643894	1.0	10181.61023835046	0	1	2	4	0.9855072463768119	0.9710144927536234	0.9371980676328503	0.9227053140096618	0.9465772432932483	0.9532326035563785	0.9555281460924386	0.969335663137698
Burosumab	5.0	Human	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223702/
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761068s000lbl.pdf"	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNHYMHWVRQAPGQGLEWMGIINPISGSTSNAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDIVDAFDFWGQGTMVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNDYFTFGPGTKVDIK	95.3458	0.17450000000000002	0.847293026813762	0.3618433	0.9473875181422352	0.998	9093.291972696488	0	1	4	5	0.9516908212560393	0.908212560386474	0.8405797101449278	0.7874396135265701	0.7743258985164656	0.7678504128550406	0.7492548052215032	0.7494603761948814
Canakinumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881252/#R77	QVQLVESGGGVVQPGRSLRLSCAASGFTFSVYGMNWVRQAPGKGLEWVAIIWYDGDNQYYADSVKGRFTISRDNSKNTLYLQMNGLRAEDTAVYYCARDLRTGPFDYWGQGTLVTVSS	EIVLTQSPDFQSVTPKEKVTITCRASQSIGSSLHWYQQKPDQSPKLLIKYASQSFSGVPSRFSGSGSGTDFTLTINSLEAEDAAAYYCHQSSSLPFTFGPGTKVDIK	80.67487	0.11050000000000004	-1.1777849243711997	0.3631978	0.9351338507840964	1.0	6729.828271642372	1	2	5	8	0.9808612440191393	0.9425837320574166	0.8995215311004786	0.8803827751196173	0.9243357426448161	0.8536512945807475	0.8795938104448747	0.9258033866096578
Cemiplimab	1.3	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761097s000lbl.pdf	EVQLLESGGVLVQPGGSLRLSCAASGFTFSNFGMTWVRQAPGKGLEWVSGISGGGRDTYFADSVKGRFTISRDNSKNTLYLQMNSLKGEDTAVYYCVKWGNIYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDSITITCRASLSINTFLNWYQQKPGKAPNLLIYAASSLHGGVPSRFSGSGSGTDFTLTIRTLQPEDFATYYCQQSSNTPFTFGPGTVVDFR	84.328135	0.16899999999999998	-0.43150514362953474	0.51688236	0.843238277817717	0.997	7492.569314607404	4	4	12	17	0.9278846153846145	0.8749999999999993	0.6874999999999998	0.6298076923076923	0.6894094380796485	0.6808510638297853	0.469858156028368	0.4814852700490996
Cendakimab	3.0	Humanized	https://www.gastrojournal.org/article/S0016-5085(18)35208-9/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F	EVTLRESGPGLVKPTQTLTLTCTLYGFSLSTSDMGVDWIRQPPGKGLEWLAHIWWDDVKRYNPALKSRLTISKDTSKNQVVLKLTSVDPVDTATYYCARTVSSGYIYYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTISCRASQDIRNYLNWYQQKPGKAPKLLIFYTSKLHSGVPSRFSGSGSGTDYTLTISSLQPEDIATYYCQQGNTLPLTFGGGTKVEIK	80.97457	-0.6515	-0.9675805109306959	0.88982785	0.7992173846972115	0.5955	7008.282588481921	10	18	21	23	0.8598130841121481	0.7570093457943913	0.6168224299065413	0.5607476635514016	0.4977629747464669	0.4121097633724323	0.24743156359779758	0.2589481010141175
Certolizumab	8.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGYVFTDYGMNWVRQAPGKGLEWMGWINTYIGEPIYADSVKGRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCARGYRSYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQNVGTNVAWYQQKPGKAPKALIYSASFLYSGVPYRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPLTFGQGTKVEIK	83.62117	0.6759999999999999	-1.8079921109203894	0.74315083	0.797679391731348	0.8585	7501.767142301094	11	14	15	16	0.8516746411483259	0.746411483253589	0.6411483253588517	0.6267942583732057	0.47756116597102194	0.3647052835182744	0.2999677627337202	0.46919644372051944
Cetuximab	5.0	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA	DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK	61.67856999999999	-1.6535000000000002	-3.997097091544892	1.4282376	0.6179612031728579	0.0025	4760.048469204516	6	13	22	25	0.6619047619047618	0.4761904761904761	0.2523809523809524	0.1904761904761905	0.03714961161769656	0.026511313745356164	0.02077001013171217	0.03047956771361028
Cinpanemab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771554/	EVQLVESGGGLVEPGGSLRLSCAVSGFDFEKAWMSWVRQAPGQGLQWVARIKSTADGGTTSYAAPVEGRFIISRDDSRNMLYLQMNSLKTEDTAVYYCTSAHWGQGTLVTVSS	SYELTQPPSVSVSPGQTARITCSGEALPMQFAHWYQQRPGKAPVIVVYKDSERPSGVPERFSGSSSGTTATLTITGVQAEDEADYYCQSPDSTNTYEVFGGGTKLTVL	89.514985	-0.1255	-1.0216500513245907	0.5910596	0.8416502785971812	0.99	6142.0588521310165	6	9	15	15	0.8390243902439027	0.7317073170731709	0.575609756097561	0.5414634146341464	0.44590036325895366	0.3025428126621701	0.17994291645044116	0.23559937727036842
Clazakizumab	1.8	Humanized	https://onlinelibrary.wiley.com/doi/full/10.1002/art.39700	EVQLVESGGGLVQPGGSLRLSCAASGFSLSNYYVTWVRQAPGKGLEWVGIIYGSDETAYATSAIGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDDSSDWDAKFNLWGQGTLVTVSS	AIQMTQSPSSLSASVGDRVTITCQASQSINNELSWYQQKPGKAPKLLIYRASTLASGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQGYSLRNIDNAFGGGTKVEIK	80.71977	0.634	-0.7380136536100143	0.70528865	0.8056818181818182	0.9530000000000001	6907.436009095445	5	6	12	13	0.7943925233644851	0.738317757009345	0.6588785046728969	0.6355140186915887	0.22600583283621378	0.34122091867169946	0.36914230794723824	0.49791210976337225
Clivatuzumab	10.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLQQSGAEVKKPGASVKVSCEASGYTFPSYVLHWVKQAPGQGLEWIGYINPYNDGTQYNEKFKGKATLTRDTSINTAYMELSRLRSDDTAVYYCARGFGGSYGFAYWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTMTCSASSSVSSSYLYWYQQKPGKAPKLWIYSTSNLASGVPARFSGSGSGTDFTLTISSLQPEDSASYFCHQWNRYPYTFGGGTRLEIK	77.33997	-0.6315	-1.709013811510598	0.8369526	0.7712418300653594	0.6675	6427.523186089244	9	11	12	12	0.7772511848341239	0.6824644549763041	0.5402843601895735	0.4881516587677724	0.18369130449396845	0.1630701489025591	0.14584383718194352	0.17487647474034476
Coltuximab	33.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557033/	QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS	EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTDYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK	81.146185	-1.327	-3.209881295751406	1.0836477	0.7099358974358975	0.23750000000000002	5475.142744819618	5	12	15	15	0.7163461538461534	0.5288461538461536	0.4038461538461538	0.298076923076923	0.08023049645389974	0.06396617566830302	0.08810692853246035	0.07910529187124929
Conatumumab	0.0	Human	https://link.springer.com/article/10.1007/s00280-010-1544-1	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYFWSWIRQLPGKGLEWIGHIHNSGTTYYNPSLKSRVTISVDTSKKQFSLRLSSVTAADTAVYYCARDRGGDYYYGMDVWGQGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQGISRSYLAWYQQKPGQAPSLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQFGSSPWTFGQGTKVEIK	90.905785	0.41150000000000003	0.45205911190747355	0.36302596	0.9143139040680024	1.0	9101.425443786666	0	0	3	5	0.9999999999999991	0.9579439252336441	0.8831775700934574	0.808411214953271	0.9999999999999973	0.9189202624776267	0.8221150659508166	0.7917080930602505
Concizumab	17.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQTPEKRLEWVATISRSGSYSYFPDSVQGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGGYDEGDAMDSWGQGTTVTVSS	DIVMTQTPLSLSVTPGQPASISCKSSQSLLESDGKTYLNWYLQKPGQSPQLLIYLVSILDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQATHFPQTFGGGTKVEIK	82.04717	-0.389	-1.793225381825903	0.6650487	0.8472550177095632	0.6595000000000001	7410.897521013342	4	7	15	16	0.8847926267281104	0.8248847926267279	0.6866359447004606	0.6497695852534562	0.5721067424910935	0.5778099160048366	0.4674069353204557	0.5366212373762133
Crenezumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962917/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLELVASINSNGGSTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCASGDYWGQGTTVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSQSLVYSNGDTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK	92.09168500000001	0.0025000000000000577	-1.0837079965968475	0.41710946	0.8794642857142857	0.8454999999999999	8136.346079383998	3	4	6	9	0.9423076923076917	0.9038461538461533	0.8221153846153844	0.7740384615384615	0.7349972722313122	0.7508183306055626	0.7175395526459353	0.7312465902891434
Crizanlizumab	0.9	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761128s000lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKVSGYTFTSYDINWVRQAPGKGLEWMGWIYPGDGSIKYNEKFKGRVTMTVDKSTDTAYMELSSLRSEDTAVYYCARRGEYGNYEGAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQSVDYDGHSYMNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSDENPLTFGGGTKVEIK	82.505535	0.1545	-0.8698572958705648	0.7110777	0.8180844779205434	0.8674999999999999	7430.067260545987	1	1	2	5	0.8248847926267278	0.7649769585253453	0.7188940092165897	0.6866359447004609	0.36381017746837724	0.4423146060071241	0.5356652613001273	0.6069140765434522
Dacetuzumab	0.0	Humanized	https://jhoonline.biomedcentral.com/articles/10.1186/1756-8722-7-44	EVQLVESGGGLVQPGGSLRLSCAASGYSFTGYYIHWVRQAPGKGLEWVARVIPNAGGTSYNQKFKGRFTLSVDNSKNTAYLQMNSLRAEDTAVYYCAREGIYWWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSQSLVHSNGNTFLHWYQQKPGKAPKLLIYTVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYFCSQTTHVPWTFGQGTKVEIK	85.93072000000001	0.3145	-1.6859361127789425	0.8147971	0.7745144110275689	0.7845	6755.345812954884	2	6	13	16	0.8380952380952374	0.7571428571428566	0.6619047619047617	0.6047619047619047	0.4399696048632173	0.41286727456939865	0.38120567375886416	0.3822188449848023
Daclizumab	19.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYRMHWVRQAPGQGLEWIGYINPSTGYTEYNQKFKDKATITADESTNTAYMELSSLRSEDTAVYYCARGGGVFDYWGQGTLVTVSS	DIQMTQSPSTLSASVGDRVTITCSASSSISYMHWYQQKPGKAPKLLIYTTSNLASGVPARFSGSGSGTEFTLTISSLQPDDFATYYCHQRSTYPLTFGQGTKVEVK	89.61363499999999	-0.1335	-0.9449870111765726	0.6181934	0.8245770982433311	0.7765	7348.736425357546	3	6	11	12	0.8349514563106795	0.7766990291262135	0.6941747572815533	0.6601941747572815	0.4199029126213579	0.47586586793362234	0.4880534324864005	0.5589237760793223
Dalotuzumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753462/	QVQLQESGPGLVKPSETLSLTCTVSGYSITGGYLWNWIRQPPGKGLEWIGYISYDGTNNYKPSLKDRVTISRDTSKNQFSLKLSSVTAADTAVYYCARYGRVFFDYWGQGTLVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSQSIVHSNGNTYLQWYLQKPGQSPQLLIYKVSNRLYGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPWTFGQGTKVEIK	86.963485	-0.6465	-1.5550938036469661	0.6482926	0.8603861416361416	0.87	7329.515845076869	5	9	17	18	0.9014084507042242	0.812206572769952	0.6431924882629103	0.60093896713615	0.6108780341624175	0.5553308027836027	0.3068541271268254	0.37001798022175536
Dapirolizumab	8.9	Humanized	https://journals.sagepub.com/doi/full/10.1177/0961203315574558	EVQLVESGGGLVQPGGSLRLSCAVSGFSSTNYHVHWVRQAPGKGLEWMGVIWGDGDTSYNSVLKSRFTISRDTSKNTVYLQMNSLRAEDTAVYYCARQLTHYYVLAAWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASEDLYYNLAWYQRKPGKAPKLLIYDTYRLADGVPSRFSGSGSGTDYTLTISSLQPEDFASYYCQQYYKFPFTFGQGTKVEIK	77.61652000000001	0.2915	-1.9360758947267425	0.90221715	0.7760573419927135	0.7985	6595.309205147151	13	19	20	22	0.7655502392344505	0.6842105263157899	0.6220095693779906	0.5885167464114833	0.14970816790525854	0.1655468458379998	0.25923852183650636	0.3258424106688386
Daratumumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLLESGGGLVQPGGSLRLSCAVSGFTFNSFAMSWVRQAPGKGLEWVSAISGSGGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYFCAKDKILWFGEPVFDYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK	93.62582	1.1524999999999999	0.8650543606249658	0.4198099	0.9245058985751494	1.0	9859.495203346596	5	6	9	9	0.9624413145539904	0.9389671361502345	0.892018779342723	0.8873239436619719	0.8166933040322305	0.8390853394599269	0.8543185828921521	0.9307262011787034
Denosumab	1.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSGITGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGTTVIMSWFDPWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVRGRYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVFYCQQYGSSPRTFGQGTKVEIK	93.011835	1.2309999999999999	0.5388880716445213	0.31204173	0.9225106253794778	1.0	9938.363433285736	0	1	1	1	0.9672897196261675	0.9392523364485975	0.9018691588785044	0.8738317757009345	0.8364651686882719	0.8399449857493185	0.885182607542917	0.9145953469874727
Depatuxizumab	5.0	Humanized/Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303422/	QVQLQESGPGLVKPSQTLSLTCTVSGYSISSDFAWNWIRQPPGKGLEWMGYISYSGNTRYQPSLKSRITISRDTSKNQFFLKLNSVTAADTATYYCVTAGRGFPYWGQGTLVTVSS	DIQMTQSPSSMSVSVGDRVTITCHSSQDINSNIGWLQQKPGKSFKGLIYHGTNLDDGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCVQYAQFPWTFGGGTKLEIK	86.28687	-0.789	-1.7747272627650426	0.7365717	0.7743312922977763	0.6135	6319.966091319608	6	10	19	19	0.7342995169082134	0.6618357487922713	0.4830917874396138	0.42512077294686	0.10386473429951777	0.1339551855278038	0.11634460547504032	0.1294754513995957
Derlotuximab	33.3	Chimeric	https://pubmed.ncbi.nlm.nih.gov/16918301/	QVQLKESGPGLVAPSQSLSITCTVSGFSLTDYGVRWIRQPPGKGLEWLGVIWGGGSTYYNSALKSRLSISKDNSKSQVFLKMNSLQTDDTAMYYCAKEKRRGYYYAMDYWGQGTSVTVSS	ENVLTQSPAIMSASPGEKVTMTCRASSSVSSSYLHWYQQKSGASPKLWIYSTSNLASGVPARFSGSGSGTSYSLTISSVEAEDAATYYCQQYSGYPLTFGGGTKLEIK	67.35887	-1.129	-3.207859816299507	1.2293532	0.6805555555555556	0.0	5318.095816085996	10	21	28	30	0.7783018867924532	0.5235849056603774	0.2877358490566038	0.2311320754716981	0.18667201926937052	0.05650341228422328	0.03997725143851195	0.05024755787501663
Dinutuximab	17.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLLQSGPELEKPGASVMISCKASGSSFTGYNMNWVRQNIGKSLEWIGAIDPYYGGTSYNQKFKGRATLTVDKSSSTAYMHLKSLTSEDSAVYYCVSGMEYWGQGTSVTVSS	EIVMTQSPATLSVSPGERATLSCRSSQSLVHRNGNTYLHWYLQKPGQSPKLLIHKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDLGVYFCSQSTHVPPLTFGAGTKLELK	81.01437	-1.499	-3.4746793325150818	1.311592	0.6946902654867257	0.131	5464.766774021026	10	16	22	22	0.714285714285714	0.5428571428571426	0.357142857142857	0.3142857142857142	0.07548125633231952	0.07066869300911832	0.0638297872340424	0.08839918946301918
Disitamab	58.6	Humanized	https://www.sciencedirect.com/science/article/pii/S0378427419304217?via%3Dihub	EVQLVQSGAEVKKPGATVKISCKVSGYTFTDYYIHWVQQAPGKGLEWMGRVNPDHGDSYYNQKFKDKATITADKSTDTAYMELSSLRSEDTAVYFCARNYLFDHWGQGTLVTVSS	DIQMTQSPSSVSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASIRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCHQFATYTFGGGTKVEIK	96.295	-0.497	-1.346867087418364	0.82585686	0.8277432712215321	0.7985	7058.443605707635	7	9	10	15	0.7990196078431367	0.7352941176470583	0.691176470588235	0.5784313725490196	0.23995271867612133	0.3235294117647026	0.4800792657488518	0.29985398414685005
Domagrozumab	9.4	Humanized	https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.386	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSTISSGGSYTSYPDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQDYAMNYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVSTAVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHYSTPWTFGGGTKVEIK	94.744685	1.0005	-1.2521373453456213	0.38480783	0.8778198517563648	0.837	8407.945394741299	3	3	7	7	0.8888888888888894	0.8357487922705319	0.7681159420289857	0.7342995169082126	0.5837273443656438	0.5960530373111325	0.6403792784458842	0.6839174975160175
Dupilumab	4.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761055s014lbl.pdf	EVQLVESGGGLEQPGGSLRLSCAGSGFTFRDYAMTWVRQAPGKGLEWVSSISGSGGNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDRLSITIRPRYYGLDVWGQGTTVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSQSLLYSIGYNYLDWYLQKSGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGFYYCMQALQTPYTFGQGTKLEIK	90.105385	-0.125	0.2592886140481868	0.47381768	0.9012142857142857	0.9975	8778.43086109357	4	5	9	9	0.9547511312217191	0.941176470588235	0.8778280542986424	0.8552036199095022	0.7862632778152162	0.8474134334584882	0.8056625268765442	0.8834841628959275
Durvalumab	3.3	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGGWFGELAFDYWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIK	93.81756999999999	1.208	0.7803965748024544	0.2600917	0.9401591674318945	1.0	10335.419824713645	0	0	1	1	0.9906103286384971	0.9765258215962437	0.9530516431924879	0.92018779342723	0.9700329637398842	0.9688675789964362	0.9761096127592976	0.9648719741617553
Dusigitumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377301/	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYDINWVRQATGQGLEWMGWMNPNSGNTGYAQKFQGRVTMTRNTSISTAYMELSSLRSEDTAVYYCARDPYYYYYGMDVWGQGTTVTVSS	QSVLTQPPSVSAAPGQKVTISCSGSSSNIENNHVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCETWDTSLSAGRVFGGGTKLTVL	93.594685	0.13249999999999998	0.9375272761817564	0.16524501	0.9386261261261262	1.0	9657.179421126555	0	1	1	3	0.9999999999999997	0.981395348837209	0.9162790697674418	0.8930232558139535	0.9999999999999991	0.9804552201880254	0.9113887514431799	0.9369124195942602
Eculizumab	2.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK	81.79187	-0.07949999999999999	-1.539390499620658	0.6682833	0.8093304734181094	0.9339999999999999	7294.469585495056	8	11	17	18	0.7840375586854454	0.7042253521126755	0.6150234741784035	0.5868544600938966	0.20007991209669257	0.2074967535710697	0.24296607065561163	0.3214214364199378
Edrecolomab	80.0	Mouse	https://pubmed.ncbi.nlm.nih.gov/7909866/	QVQLQQSGAELVRPGTSVKVSCKASGYAFTNYLIEWVKQRPGQGLEWIGVINPGSGGTNYNEKFKGKATLTADKSSSTAYMQLSSLTSDDSAVYFCARDGPWFAYWGQGTLVTVSA	NIVMTQSPKSMSMSVGERVTLTCKASENVVTYVSWYQQKPEQSPKLLIYGASNRYTGVPDRFTGSGSATDFTLTISSVQAEDLADYHCGQGYSYPYTFGGGTKLEIK	79.82212000000001	-1.3915	-3.806163937435673	1.1925778	0.6949323235578473	0.0025	5351.668553354355	9	14	19	19	0.6570048309178746	0.526570048309179	0.3188405797101451	0.2657004830917874	0.034398876212012236	0.06073765717614037	0.0460992907801418	0.06787268304382083
Efalizumab	6.3	Humanized	https://www.fda.gov/media/75713/download	EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIK	82.06967	0.847	-1.6440967394760113	0.86781263	0.8111531628948792	0.627	7851.246692166831	6	7	12	13	0.8679245283018878	0.7641509433962272	0.6509433962264154	0.6226415094339623	0.5221129399170377	0.4401177572594696	0.3339689549043236	0.4522614746420448
Eldelumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946756/	QMQLVESGGGVVQPGRSLRLSCTASGFTFSNNGMHWVRQAPGKGLEWVAVIWFDGMNKFYVDSVKGRFTISRDNSKNTLYLEMNSLRAEDTAIYYCAREGDGSGIYYYYGMDVWGQGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPIFTFGPGTKVDIK	91.6431	0.8565	0.036230297632454	0.4778066	0.9176901450133177	1.0	9449.911753865948	2	3	4	4	0.9585253456221194	0.9354838709677417	0.8755760368663593	0.8663594470046082	0.8009853907245794	0.8285861358956752	0.8008710004248779	0.9032830016014642
Elotuzumab	18.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFDFSRYWMSWVRQAPGKGLEWIGEINPDSSTINYAPSLKDKFIISRDNAKNSLYLQMNSLRAEDTAVYYCARPDGNYWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVGIAVAWYQQKPGKVPKLLIYWASTRHTGVPDRFSGSGSGTDFTLTISSLQPEDVATYYCQQYSSYPYTFGQGTKVEIK	81.53092000000001	0.706	-1.4187482344159257	0.70609426	0.8281237728736355	0.5905	7542.839701389915	2	6	7	7	0.8476190476190472	0.7571428571428568	0.7095238095238093	0.6714285714285714	0.4683383991894621	0.41286727456940026	0.5221209050996282	0.5818135764944274
Emapalumab	3.5	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761107lbl.pdf	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSSGWYVPHWFDPWGQGTLVTVSS	NFMLTQPHSVSESPGKTVTISCTRSSGSIASNYVQWYQQRPGSSPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLKTEDEADYYCQSYDGSNRWMFGGGTKLTVL	92.14617	0.7035	0.8934222847786095	0.22201666	0.9368270709734126	1.0	10045.746227504262	0	0	0	0	0.958715596330275	0.9357798165137613	0.908256880733945	0.8944954128440368	0.8017275034159664	0.8294781703428977	0.8987735051076841	0.9390005855943784
Emibetuzumab	0.0	Humanized	https://clincancerres.aacrjournals.org/content/23/8/1910	QVQLVQSGAEVKKPGASVKVSCKASGYTFTDYYMHWVRQAPGQGLEWMGRVNPNRRGTTYNQKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARANWLDYWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCSVSSSVSSIYLHWYQQKPGKAPKLLIYSTSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQVYSGYPLTFGGGTKVEIK	90.94557	-0.15300000000000002	-1.031547454971039	0.48030445	0.8517310789049919	0.9215	7859.024650610698	3	7	9	10	0.8647342995169089	0.797101449275363	0.7198067632850245	0.676328502415459	0.5124970020899736	0.5216877376914394	0.5369599479220204	0.5887638332134172
Emicizumab	3.5	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761083s002s004lbl.pdf	QVQLVQSGSELKKPGASVKVSCKASGYTFTDNNMDWVRQAPGQGLEWMGDINTRSGGSIYNEEFQDRVIMTVDKSTDTAYMELSSLRSEDTATYHCARRKSYGYYLDEWGEGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASRNIERQLAWYQQKPGQAPELLIYQASRKESGVPDRFSGSRYGTDFTLTISSLQPEDIATYYCQQYSDPPLTFGGGTKVEIK	76.48737	-0.6575	-2.455603175629684	0.95330566	0.7720882745621613	0.8685	6322.342916434779	11	14	14	15	0.7238095238095231	0.6190476190476186	0.5428571428571427	0.4857142857142857	0.09270516717325145	0.0938027693346841	0.14994934143870287	0.17401215805471118
Enfortumab	1.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761137s000lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYNMNWVRQAPGKGLEWVSYISSSSSTIYYADSVKGRFTISRDNAKNSLSLQMNSLRDEDTAVYYCARAYYYGMDVWGQGTTVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISGWLAWYQQKPGKAPKFLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQANSFPPTFGGGTKVEIK	93.16582	0.973	0.7504109766364886	0.25671032	0.9335010783608915	1.0	10388.317486244829	0	0	0	0	0.9999999999999998	0.9951923076923075	0.9903846153846152	0.9759615384615383	0.9999999999999991	0.9957378614293505	0.9948854337152208	0.99645390070922
Enokizumab	9.0	Humanized	https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-14-93	QVQLVQSGAEVKKPGSSVKVSCKASGGTFSYYWIEWVRQAPGQGLEWMGEILPGSGTTNPNEKFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARADYYGSDYVKFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQHVITHVTWYQQKPGKAPKLLIYGTSYSYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFYEYPLTFGGGTKVEIK	83.95787	0.0195	-1.3866608009118018	0.6588343	0.8303968132373218	0.888	7184.525006713094	6	9	10	11	0.7699530516431918	0.718309859154929	0.657276995305164	0.6338028169014084	0.1629790563713227	0.25347118170012767	0.36204341890586894	0.4930576365997401
Erenumab	2.4	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900095/	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAVISFDGSIKYSVDSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCARDRLNYYDSSGYYHYKYYGMAVWGQGTTVTVSS	QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSTTLGITGLQTGDEADYYCGTWDSRLSAVVFGGGTKLTVL	91.386385	0.837	0.3674281431653784	0.47364417	0.884965034965035	1.0	8904.17775473379	5	5	9	11	0.9419642857142851	0.9241071428571423	0.8973214285714282	0.825892857142857	0.7335359675785182	0.7953394123606875	0.8721821175278609	0.8220934650455922
Etaracizumab	0.0	Humanized	https://link.springer.com/article/10.1007%2Fs10637-007-9077-0	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVAKVSSGGGSTYYLDTVQGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHLHGSFASWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCQASQSISNFLHWYQQRPGQAPRLLIRYRSQSISGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSGSWPLTFGGGTKVEIK	83.55187000000001	0.6065	-0.993553292164453	0.6120241	0.8346912692707085	0.945	7676.487980836519	9	12	17	17	0.8605769230769227	0.7788461538461534	0.6874999999999999	0.6682692307692307	0.49996590289143344	0.48233769776322843	0.4698581560283684	0.5761047463175121
Etrolizumab	5.0	Humanized	https://www.gastrojournal.org/article/S0016-5085(13)01659-4/fulltext	EVQLVESGGGLVQPGGSLRLSCAASGFFITNNYWGWVRQAPGKGLEWVGYISYSGSTSYNPSLKSRFTISRDTSKNTFYLQMNSLRAEDTAVYYCARTGSSGYFDFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASESVDDLLHWYQQKPGKAPKLLIKYASQSISGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNSLPNTFGQGTKVEIK	82.60072	0.8019999999999999	-1.2014457058930592	0.6860098	0.8226695422957104	0.7625	7470.247099637962	3	4	5	15	0.9038461538461531	0.8605769230769225	0.7692307692307689	0.6923076923076922	0.6186579378068713	0.6416052918712478	0.6433442444080734	0.6171576650300052
Evolocumab	0.3	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125522s014lbl.pdf	EVQLVQSGAEVKKPGASVKVSCKASGYTLTSYGISWVRQAPGQGLEWMGWVSFYNGNTNYAQKLQGRGTMTTDPSTSTAYMELRSLRSDDTAVYYCARGYGMDVWGQGTTVTVSS	ESALTQPASVSGSPGQSITISCTGTSSDVGGYNSVSWYQQHPGKAPKLMIYEVSNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCNSYTSTSMVFGGGTKLTVL	96.645	0.16050000000000003	0.2735494689841194	0.41153258	0.9246509772636617	0.935	9557.889605003038	0	3	5	5	0.9951923076923074	0.9374999999999998	0.875	0.875	0.9846563011456617	0.834663120567375	0.799645390070922	0.9166666666666667
Farletuzumab	8.7	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGVVQPGRSLRLSCSASGFTFSGYGLSWVRQAPGKGLEWVAMISSGGSYTYYADSVKGRFAISRDNAKNTLFLQMDSLRPEDTGVYFCARHGDDPAWFAYWGQGTPVTVSS	DIQLTQSPSSLSASVGDRVTITCSVSSSISSNNLHWYQQKPGKAPKPWIYGTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSYPYMYTFGQGTKVEIK	78.82437	0.008500000000000008	-1.5813458629246018	0.75120693	0.7862108479755539	0.7895000000000001	6767.177779866847	4	8	10	12	0.830985915492957	0.7605633802816896	0.6197183098591547	0.5539906103286385	0.39459094995504407	0.4305763659974012	0.2546199180901002	0.24963373622348742
Ficlatuzumab	0.0	Humanized	"https://www.ncbi.nlm.nih.gov/pubmed/24901237
https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.427"	QVQLVQPGAEVKKPGTSVKLSCKASGYTFTTYWMHWVRQAPGQGLEWIGEINPTNGHTNYNQKFQGRATLTVDKSTSTAYMELSSLRSEDTAVYYCARNYVGSIFDYWGQGTLLTVSS	DIVMTQSPDSLAMSLGERVTLNCKASENVVSYVSWYQQKPGQSPKLLIYGASNRESGVPDRFSGSGSATDFTLTISSVQAEDVADYHCGQSYNYPYTFGQGTKLEIK	79.50502	-0.615	-1.7662687666439547	0.7738985	0.7955013464280056	0.62	6449.083470679097	1	5	10	11	0.8229665071770341	0.7320574162679432	0.6507177033492826	0.5789473684210527	0.3546268960602698	0.30459126539754006	0.3329685432149051	0.30095184770436734
Fletikumab	1.7	Human	https://link.springer.com/article/10.1007/s12325-015-0191-7	QVQLVQSGAEVKRPGASVKVSCKASGYTFTNDIIHWVRQAPGQRLEWMGWINAGYGNTQYSQNFQDRVSITRDTSASTAYMELISLRSEDTAVYYCAREPLWFGESSPHDYYGMDVWGQGTTVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK	87.53811999999999	0.04149999999999998	0.6549077261093667	0.6117219	0.9001030245051144	0.9975	8313.63842491919	1	3	5	7	0.935779816513761	0.8715596330275225	0.793577981651376	0.7706422018348624	0.7124568937471518	0.6710911575248868	0.6751577851519291	0.7276335480512721
Fontolizumab	7.8	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1856291/	QVQLVQSGAELKKPGSSVKVSCKASGYIFTSSWINWVKQAPGQGLEWIGRIDPSDGEVHYNQDFKDKATLTVDKSTNTAYMELSSLRSEDTAVYYCARGFLPWFADWGQGTLVTVSS	DIQMTQSPSTLSASVGDRVTITCKASENVDTYVSWYQQKPGKAPKLLIYGASNRYTGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCGQSYNYPFTFGQGTKVEVK	77.08787000000001	-0.4385	-2.436383473782392	0.9891935	0.7736640306733764	0.6685000000000001	6673.511787216839	4	5	9	9	0.7548076923076917	0.6923076923076918	0.596153846153846	0.5721153846153846	0.12745499181669323	0.17825968357883154	0.20485542825968342	0.28641571194762677
Fremanezumab	1.6	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761089s000lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWISWVRQAPGKGLEWVAEIRSESDASATHYAEAVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCLAYFDYGLAIQNYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCKASKRVTTYVSWYQQKPGQAPRLLIYGASNRYLGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCSQSYNYPYTFGQGTKLEIK	81.978635	0.3365	-0.42386085939729046	0.7128527	0.8192508043511567	0.9275	6922.490354327117	10	14	17	19	0.7746478873239429	0.7276995305164312	0.6666666666666663	0.6338028169014084	0.17630606333033427	0.28480338294542457	0.3989361702127645	0.4930576365997401
Frovocimab	6.5	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852062/	EVQLVESGGGLVKPGGSLRLSCAASGFPFSKLGMVWVRQAPGKGLEWVSTISSGGGYTYYPDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGISFQGGTYTYVMDYWGQGTLVTVSS	DIVMTQSPLSLPVTPGEPASISCRSSKSLLHRNGITYSYWYLQKPGQSPQLLIYQLSNLASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCYQNLELPLTFGQGTKVEIK	83.973435	-0.248	-0.9835605277752233	0.6369194	0.8370357142857143	0.9145	7178.8311638505065	13	17	19	20	0.8009049773755652	0.7285067873303165	0.67420814479638	0.6606334841628959	0.2469192259555194	0.2875228651198603	0.4270161419723367	0.5598584769423317
Fulranumab	2.9	Human	https://journals.lww.com/clinicalpain/FullText/2017/02000/Fulranumab_in_Patients_With_Pain_Associated_With.2.aspx	EVQLVESGGGLVQPGGSLRLSCAASGFTLRSYSMNWVRQAPGKGLEWVSYISRSSHTIFYADSVKGRFTISRDNAKNSLYLQMDSLRDEDTAMYYCARVYSSGWHVSDYFDYWGQGILVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK	88.99897	0.8805	0.4773941134047395	0.47007304	0.9174834739001595	0.9924999999999999	8787.28721598592	4	4	5	13	0.9345794392523359	0.9158878504672893	0.906542056074766	0.8598130841121494	0.7088387353350551	0.7800424206270294	0.8951249420030482	0.894926095313846
Futuximab	0.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172077/	EVQLQQPGSELVRPGASVKLSCKASGYTFTSYWMHWVKQRPGQGLEWIGNIYPGSRSTNYDEKFKSKATLTVDTSSSTAYMQLSSLTSEDSAVYYCTRNGDYYVSSGDAMDYWGQGTSVTVSS	DIQMTQTTSSLSASLGDRVTISCRTSQDIGNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDFSLTINNVEQEDVATYFCQHYNTVPPTFGGGTKLEIK	68.96617	-1.3820000000000001	-3.1820158050535654	1.4392859	0.6856241926905251	0.0375	5237.656451813672	9	17	21	22	0.6588785046728967	0.5186915887850465	0.3457943925233645	0.294392523364486	0.03506329952939596	0.05049048850003291	0.05347318883807249	0.07779876715052692
Galcanezumab	8.7	Humanized	https://n.neurology.org/content/92/15_Supplement/P1.10-017	QVQLVQSGAEVKKPGSSVKVSCKASGYTFGNYWMQWVRQAPGQGLEWMGAIYEGTGKTVYIQKFADRVTITADKSTSTAYMELSSLRSEDTAVYYCARLSDYVSGFGYWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASKDISKYLNWYQQKPGKAPKLLIYYTSGYHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDALPPTFGGGTKVEIK	83.03802	0.019000000000000017	-1.792429650734125	0.8840592	0.8253357417733449	0.843	7221.170919746171	7	7	8	10	0.8142857142857138	0.7285714285714282	0.6714285714285713	0.6333333333333333	0.310030395136776	0.2877406281661588	0.4166666666666659	0.4917257683215128
Galiximab	0.0	Chimeric	https://www.annalsofoncology.org/article/S0923-7534(19)41214-3/fulltext	QVQLQESGPGLVKPSETLSLTCAVSGGSISGGYGWGWIRQPPGKGLEWIGSFYSSSGNTYYNPSLKSQVTISTDTSKNQFSLKLNSMTAADTAVYYCVRDRLFSVVGMVYNNWFDVWGPGVLVTVSS	ESALTQPPSVSGAPGQKVTISCTGSTSNIGGYDLHWYQQLPGTAPKLLIYDINKRPSGISDRFSGSKSGTAASLAITGLQTEDEADYYCQSYDSSLNAQVFGGGTRLTVL	80.95957	-0.07050000000000001	-1.5170781541488254	0.9603101	0.8073371510379385	0.6475	6755.653098910061	8	10	16	23	0.8461538461538456	0.7963800904977371	0.678733031674208	0.5927601809954751	0.4652209492635012	0.5200250312891102	0.4438641250280794	0.3400645037065563
Gancotamab	2.9	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219487/	QVQLVESGGGLVQPGGSLRLSCAASGFTFRSYAMSWVRQAPGKGLEWVSAISGRGDNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKMTSNAFAFDYWGQGTLVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGAGYGVHWYQQLPGTAPKLLIYGNTNRPSGVPDRFSGFKSGTSASLAITGLQAEDEADYYCQSYDSSLSGWVFGGGTKLTVL	92.83622	1.307	0.27937766629460636	0.44700134	0.9225528049057461	0.9975	9790.559408319388	2	3	3	3	0.9579439252336442	0.9532710280373826	0.9205607476635511	0.9018691588785046	0.7987174388546406	0.8998641214290425	0.9180585934910844	0.9481341552329821
Ganitumab	5.2	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029434/	QVQLQESGPGLVKPSGTLSLTCAVSGGSISSSNWWSWVRQPPGKGLEWIGEIYHSGSTNYNPSLKSRVTISVDKSKNQFSLKLSSVTAADTAVYYCARWTGRTDAFDIWGQGTMVTVSS	DVVMTQSPLSLPVTPGEPASISCRSSQSLLHSNGYNYLDWYLQKPGQSPQLLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQGTHWPLTFGQGTKVEIK	93.61087	-0.502	0.6417444435628467	0.25661093	0.9477415966386555	0.999	10015.67967315676	0	0	0	1	0.9767441860465116	0.9674418604651163	0.958139534883721	0.958139534883721	0.8965446148771228	0.9444581890153391	0.9806201550387595	0.9954642916048162
Gantenerumab	0.0	Human	https://www.researchgate.net/publication/264433230_Efficacy_and_safety_studies_of_gantenerumab_in_patients_with_Alzheimer's_disease	QVELVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAINASGTRTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGKGNTHKPYGYVRYFDVWGQGTLVTVSS	DIVLTQSPATLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFATYYCLQIYNMPITFGQGTKVEIK	86.27322000000001	1.225	-1.267143990422058	0.71142775	0.8611111111111112	0.995	8261.696533627724	7	10	12	12	0.8944954128440362	0.8486238532110087	0.8073394495412842	0.8027522935779815	0.5956470817880138	0.6257726592491367	0.6899603097143597	0.7886980284989263
Gatipotuzumab	9.5	Humanized	https://www.sciencedirect.com/science/article/pii/S0959804916321256	EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS	DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK	93.886635	-0.5065	-1.0396066496938554	0.66937566	0.8559218559218559	0.6739999999999999	6935.712294561877	12	13	17	22	0.7699530516431917	0.7417840375586848	0.685446009389671	0.6150234741784038	0.1629790563713227	0.3548596543801805	0.4640312323111236	0.4203126560783138
Gedivumab	1.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655070/	EVQLVESGGGVVQPGKSLRLSCAASGLTFSSYAVHWVRQAPGKGLEWVTLISYDGANQYYADSVKGRFTISRDNSKNTVYLQMNSLRPEDTAVYYCAVPGPVFGIFPPWSYFDNWGQGILVTVSS	EIVLTQSPATLSVSPGERATLSCRASQVISHNLAWYQQKPGQAPRLLIYGASTRASGIPARFSGSGSGTDYTLTITSLQSEDFAVYYCQHYSNWPPRLTFGGGTKVEIK	83.920935	0.5715	-0.5824202472993071	0.7644816	0.8403669724770643	1.0	7498.881397156915	4	5	11	14	0.9036697247706413	0.8623853211009167	0.7568807339449538	0.7110091743119265	0.618094866289281	0.6464148610839983	0.6154759580974686	0.6448695425857243
Gemtuzumab	0.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVQSGAEVKKPGSSVKVSCKASGYTITDSNIHWVRQAPGQSLEWIGYIYPYNGGTDYNQKFKNRATLTVDNPTNTAYMELSSLRSEDTAFYYCVNGNPWLAYWGQGTLVTVSS	DIQLTQSPSTLSASVGDRVTITCRASESLDNYGIRFLTWFQQKPGKAPKLLMYAASNQGSGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQTKEVPWSFGQGTKVEVK	89.146635	-0.9755	-2.270784962958605	1.0434077	0.7453401677539608	0.7735000000000001	6107.893866501603	9	10	13	15	0.6919431279620861	0.6303317535545031	0.5592417061611379	0.5308056872037916	0.05565359147591704	0.10318980874592527	0.16462471849685734	0.21284998823568987
Gevokizumab	37.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLQESGPGLVKPSQTLSLTCSFSGFSLSTSGMGVGWIRQPSGKGLEWLAHIWWDGDESYNPSLKSRLTISKDTSKNQVSLKITSVTAADTAVYFCARNRYDPPWFVDWGQGTLVTVSS	DIQMTQSTSSLSASVGDRVTITCRASQDISNYLSWYQQKPGKAVKLLIYYTSKLHSGVPSRFSGSGSGTDYTLTISSLQQEDFATYFCLQGKMLPWTFGQGTKLEIK	76.23923500000001	-0.6745	-1.828726413149098	0.79029936	0.773714953271028	0.462	6497.69525227085	8	12	15	18	0.819905213270143	0.7345971563981051	0.6587677725118487	0.6018957345971566	0.33992134718161127	0.31945144701018946	0.36865147390003883	0.3730714933951806
Glembatumumab	3.8	Human	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879709/
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.31892"	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSFNYYWSWIRHHPGKGLEWIGYIYYSGSTYSNPSLKSRVTISVDTSKNQFSLTLSSVTAADTAVYYCARGYNWNYFDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSVDNNLVWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPPWTFGQGTKVEIK	92.53352000000001	0.3015	0.6075380302677126	0.3704349	0.9302054154995332	1.0	9001.623981023837	0	1	3	7	1.000000000000001	0.9478672985781996	0.8957345971563984	0.8720379146919431	1.0	0.8770713589459205	0.8668364088602075	0.9114147423616015
Golimumab	4.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLVESGGGVVQPGRSLRLSCAASGFIFSSYAMHWVRQAPGNGLEWVAFMSYDGSNKKYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGIAAGGNYYYYGMDVWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVYSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPFTFGPGTKVDIK	92.63897	0.9894999999999999	0.44243104178292847	0.37474304	0.9259259259259258	1.0	9531.94959571151	0	1	5	9	0.9862385321100913	0.9633027522935776	0.885321100917431	0.8348623853211009	0.9500780792504373	0.934917691456828	0.8300962977422074	0.8436300344850023
Gosuranemab	6.2	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298197/	EVHLVESGGALVKPGGSLRLSCAASGFSFSKYGMSWVRQAPGKGLEWVATISSSGSRTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAMYYCSISWDGAMDYWGQGTTVTVSS	DVVMTQSPLSLPVTLGQPASISCKSSQSIVHSNGNTYLEWYLQKPGQSPQLLVYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGTYYCFQGSLVPWAFGGGTKVEIK	81.75907000000001	-0.47450000000000003	-1.6766711178042073	0.7238387	0.8168879731379732	0.6605	7227.315276761283	5	8	14	17	0.8920187793427222	0.8075117370892011	0.6760563380281687	0.6150234741784036	0.5908167682216212	0.5456830819431939	0.4338977125162308	0.4203126560783132
Gremubamab	2.5	Humanized	https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(18)30576-7/fulltext	EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMNWVRQAPGKGLEWVSAITMSGITAYYTDDVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKEEFLPGTHYYYGMDVWGQGTTVTVSS	AIQMTQSPSSLSASVGDRVTITCRASQGIRNDLGWYQQKPGKAPKLLIYSASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYCLQDYNYPWTFGQGTKVEIK	88.44229999999999	0.8394999999999999	0.007164382116613258	0.52997434	0.9166159464394401	1.0	8601.994147408699	4	7	7	7	0.8878504672897191	0.8551401869158874	0.8411214953271026	0.8317757009345793	0.5807814674885647	0.634900908066547	0.7502154172466359	0.8359680519652678
Guselkumab	6.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761061s000lbl.pdf	EVQLVQSGAEVKKPGESLKISCKGSGYSFSNYWIGWVRQMPGKGLEWMGIIDPSNSYTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARWYYKPFDVWGQGTLVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSSSNIGSGYDVHWYQQLPGTAPKLLIYGNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCASWTDGLSLVVFGGGTKLTVL	90.07987	0.5599999999999999	-0.13083598432419635	0.37812015	0.8991683991683992	1.0	9052.525138156168	1	2	4	6	0.910377358490567	0.8726415094339629	0.8537735849056608	0.8066037735849058	0.6394353004148297	0.6741603104509586	0.7699718988358095	0.7907466880770775
Ibalizumab	15.0	Humanized	https://aac.asm.org/content/53/2/450	QVQLQQSGPEVVKPGASVKMSCKASGYTFTSYVIHWVRQKPGQGLDWIGYINPYNDGTDYDEKFKGKATLTSDTSTSTAYMELSSLRSEDTAVYYCAREKDNYATGAWFAYWGQGTLVTVSS	DIVMTQSPDSLAVSLGERVTMNCKSSQSLLYSTNQKNYLAWYQQKPGQSPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSVQAEDVAVYYCQQYYSYRTFGGGTKLEIK	82.28832	-0.565	-1.3989544538943899	1.0678885	0.8115485948477752	0.5025	6754.580842032657	7	9	14	16	0.8073394495412839	0.7201834862385316	0.5642201834862383	0.5229357798165136	0.2754408224347691	0.2594833756262589	0.16788665495477878	0.20473030125577446
Ibritumomab	1.9	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSA	QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGAGTKLELK	65.62782	-1.755	-3.3146551031818388	1.3543398	0.662155892360037	0.0005	4800.138629707088	15	19	27	31	0.6037735849056604	0.4198113207547169	0.1981132075471698	0.1179245283018868	0.0077612739194432585	0.0035460992907801	0.0035460992907801	0.00635621570988886
Icrucumab	0.0	Human	https://link.springer.com/article/10.1007/s10637-013-9998-8	QAQVVESGGGVVQSGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVRGRFTISRDNSENTLYLQMNSLRAEDTAVYYCARDHYGSGVHHYFYYGLDVWGQGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPLTFGGGTKVEIK	93.05232000000001	0.9125	0.818643545070135	0.4543897	0.9232804232804234	1.0	9206.77411712809	1	1	1	1	0.9541284403669723	0.9495412844036696	0.926605504587156	0.9220183486238532	0.7838343418569845	0.8844915088815142	0.9330633092588977	0.968117639403995
Idarucizumab	4.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQESGPGLVKPSETLSLTCTVSGFSLTSYIVDWIRQPPGKGLEWIGVIWAGGSTGYNSALRSRVSITKDTSKNQFSLKLSSVTAADTAVYYCASAAYYSYYNYDGFAYWGQGTLVTVSS	DVVMTQSPLSLPVTLGQPASISCKSSQSLLYTDGKTYLYWFLQRPGQSPRRLIYLVSKLDSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQSTHFPHTFGGGTKVEIK	81.94936999999999	-1.457	-1.1371677107539795	0.91709673	0.8145491803278688	0.8325	6888.429886320741	9	13	24	27	0.8211009174311923	0.7431192660550456	0.6055045871559632	0.5688073394495413	0.34569588131953743	0.35770056607456524	0.22172880473680764	0.2789543887045351
Imalumab	7.4	Human	https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.14289	EVQLLESGGGLVQPGGSLRLSCAASGFTFSIYSMNWVRQAPGKGLEWVSSIGSSGGTTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAGSQWLYGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSQRIMTYLNWYQQKPGKAPKLLIFVASHSQSGVPSRFRGSGSETDFTLTISGLQPEDSATYYCQQSFWTPLTFGGGTKVEIK	87.63647	0.6655000000000001	-0.8882025492422987	0.30840766	0.8574370346903215	1.0	8117.242971552805	9	12	15	16	0.8947368421052637	0.8277511961722492	0.7703349282296652	0.7607655502392345	0.5961179544606207	0.5828921917947683	0.6461620686144767	0.7154891580983406
Inclacumab	3.6	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461388/	EVQLVESGGGLVRPGGSLRLSCAASGFTFSNYDMHWVRQATGKGLEWVSAITAAGDIYYPGSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARGRYSGSGSYYNDWFDPWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPLTFGGGTKVEIK	91.81837	0.879	0.6320759796226793	0.45947498	0.9221058185107024	1.0	9376.043960109911	0	1	2	2	0.9720930232558136	0.9441860465116276	0.883720930232558	0.8558139534883721	0.8627329704766593	0.8607537522678531	0.8241382154049146	0.8849991753257462
Indusatumab	0.0	Human	https://clincancerres.aacrjournals.org/content/22/20/5049	QVQLQQWGAGLLKPSETLSLTCAVFGGSFSGYYWSWIRQPPGKGLEWIGEINHRGNTNDNPSLKSRVTISVDTSKNQFALKLSSVTAADTAVYYCARERGYTYGNFDHWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSVSRNLAWYQQKPGQAPRLLIYGASTRATGIPARFSGSGSGTEFTLTIGSLQSEDFAVYYCQQYKTWPRTFGQGTNVEIK	91.44528500000001	0.15149999999999997	0.7289611854327573	0.37301302	0.8991203958218801	1.0	8906.836920040034	0	0	1	1	0.971428571428571	0.9476190476190473	0.895238095238095	0.8619047619047618	0.8579027355623067	0.8759709557581885	0.8651637960148593	0.8977541371158393
Infliximab	30.5	Chimeric	http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103772s5359lbl.pdf	EVKLEESGGGLVQPGGSMKLSCVASGFIFSNHWMNWVRQSPEKGLEWVAEIRSKSINSATHYAESVKGRFTISRDDSKSAVYLQMTDLRTEDTGVYYCSRNYYGSTYDYWGQGTTLTVSS	DILLTQSPAILSVSPGERVSFSCRASQFVGSSIHWYQQRTNGSPRLLIKYASESMSGIPSRFSGSGSGTDFTLSINTVESEDIADYYCQQSHSWPFTFGSGTNLEVK	65.935935	-1.4340000000000002	-3.1245800516838256	1.1256084	0.6776090342679127	0.04	4935.922203377623	9	17	23	26	0.7014218009478669	0.5213270142180091	0.3317535545023695	0.1943127962085308	0.059519007764444506	0.05330072938724689	0.051418439716312	0.03320056468690125
Inotuzumab	2.0	Humanized	https://link.springer.com/article/10.1186/s41120-018-0021-5	EVQLVQSGAEVKKPGASVKVSCKASGYRFTNYWIHWVRQAPGQGLEWIGGINPGNNYATYRRKFQGRVTMTADTSTSTVYMELSSLRSEDTAVYYCTREGYGNYGAWFAYWGQGTLVTVSS	DVQVTQSPSSLSASVGDRVTITCRSSQSLANSYGNTFLSWYLHKPGKAPQLLIYGISNRFSGVPDRFSGSGSGTDFTLTISSLQPEDFATYYCLQGTHQPYTFGQGTKVEIK	77.77792	-0.6040000000000001	-2.971674916130861	0.82351774	0.7589654663518299	0.8035000000000001	6561.235067905446	4	12	17	20	0.8248847926267273	0.7419354838709671	0.6451612903225804	0.6036866359447004	0.3638101774683752	0.3551818805765257	0.31348661633493374	0.3787871359937247
Ipilimumab	2.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYTMHWVRQAPGKGLEWVTFISYDGNNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAIYYCARTGWLGPFDYWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGAFSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK	93.751885	1.2530000000000001	0.32297507114296453	0.36870143	0.934871311989956	1.0	10263.532818496207	0	0	4	5	0.9809523809523807	0.9619047619047617	0.9238095238095237	0.9047619047619048	0.9247720364741632	0.9316953731847347	0.9261229314420805	0.9501857480580885
Iscalimab	1.8	Human	https://onlinelibrary.wiley.com/doi/full/10.1111/ajt.15661	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVISYEESNRYHADSVKGRFTISRDNSKITLYLQMNSLRTEDTAVYYCARDGGIAAPGPDYWGQGTLVTVSS	DIVMTQSPLSLTVTPGEPASISCRSSQSLLYSNGYNYLDWYLQKPGQSPQVLISLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCMQARQTPFTFGPGTKVDIR	90.524485	-0.24350000000000005	0.4234405706868626	0.43230912	0.9017857142857143	0.9975	8409.688823399149	1	2	4	6	0.9583333333333337	0.9305555555555559	0.8750000000000001	0.8379629629629629	0.8002364066193869	0.8137312844759662	0.7996453900709223	0.8513265038087732
Itolizumab	15.8	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407739/#__sec11title	EVQLVESGGGLVKPGGSLKLSCAASGFKFSRYAMSWVRQAPGKRLEWVATISSGGSYIYYPDSVKGRFTISRDNVKNTLYLQMSSLRSEDTAMYYCARRDYDLDYFDSWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASRDIRSYLTWYQQKPGKAPKTLIYYATSLADGVPSRFSGSGSGQDYSLTISSLESDDTATYYCLQHGESPFTLGSGTKLEIK	77.67328499999999	-0.07899999999999996	-2.3882500606213792	0.61183256	0.7818660174350114	0.163	6528.786089195443	4	9	12	19	0.8333333333333326	0.6904761904761898	0.5809523809523807	0.5142857142857142	0.4095744680851015	0.174687605538668	0.1870145221209048	0.1950354609929077
Ixekizumab	8.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGSSVKVSCKASGYSFTDYHIHWVRQAPGQGLEWMGVINPMYGTTDYNQRFKGRVTITADESTSTAYMELSSLRSEDTAVYYCARYDYFTGTGVYWGQGTLVTVSS	DIVMTQTPLSLSVTPGQPASISCRSSRSLVHSRGNTYLHWYLQKPGQSPQLLIYKVSNRFIGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHLPFTFGQGTKLEIK	83.21042	-0.9335	-1.1986898375798214	0.65609837	0.8366596638655462	0.8820000000000001	7242.826366374511	7	9	13	16	0.8186046511627902	0.7627906976744182	0.6744186046511627	0.6232558139534884	0.33300346363186334	0.4365000824674244	0.42779976909120837	0.45476661718621153
Labetuzumab	0.0	Humanized	https://ascopubs.org/doi/full/10.1200/JCO.2017.73.9011?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed	EVQLVESGGGVVQPGRSLRLSCSASGFDFTTYWMSWVRQAPGKGLEWIGEIHPDSSTINYAPSLKDRFTISRDNAKNTLFLQMDSLRPEDTGVYFCASLYFGFPWFAYWGQGTPVTVSS	DIQLTQSPSSLSASVGDRVTITCKASQDVGTSVAWYQQKPGKAPKLLIYWTSTRHTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYSLYRSFGQGTKVEIK	82.21472	0.119	-1.4483392741808303	0.8891803	0.7722371967654986	0.7345	6943.178417448764	8	10	15	17	0.8133971291866038	0.7224880382775127	0.6124401913875601	0.5454545454545454	0.305303878652148	0.26724693745970607	0.23655366656486546	0.23984526112185672
Lanadelumab	7.0	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761090s000lbl.pdf	EVQLLESGGGLVQPGGSLRLSCAASGFTFSHYIMMWVRQAPGKGLEWVSGIYSSGGITVYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYRRIGVPRRDEFDIWGQGTMVTVSS	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASTLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNTYWTFGQGTKVEIK	92.791435	1.106	-0.21251278341793883	0.6578521	0.9120785648004949	0.9975	8978.521629094515	10	12	13	15	0.891509433962265	0.8679245283018875	0.825471698113208	0.787735849056604	0.5898233641108004	0.6611467951291335	0.7223002810116425	0.749933092466212
Lebrikizumab	30.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVTLRESGPALVKPTQTLTLTCTVSGFSLSAYSVNWIRQPPGKALEWLAMIWGDGKIVYNSALKSRLTISKDTSKNQVVLTMTNMDPVDTATYYCAGDGYYPYAMDNWGQGSLVTVSS	DIVMTQSPDSLSVSLGERATINCRASKSVDSYGNSFMHWYQQKPGQPPKLLIYLASNLESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQNNEDPRTFGGGTKVEIK	79.6076	-0.857	-0.9321460972898103	0.7941062	0.7864941212398839	0.655	6331.331947217979	7	9	15	16	0.7840375586854453	0.7089201877934267	0.6150234741784035	0.5915492957746478	0.20007991209669226	0.22331268937501872	0.24296607065561163	0.33555588852262463
Levilimab	0.0	Humanized/Chimeric	https://adisinsight.springer.com/drugs/800049269	QVQLVQSGGGLVQPGGSLRLSCAASGFTFSSYYMSWVRQAPGKGLEWVSGIYSDGTTHYGDSVKGRFTISRDNAKNTVYLQLNSLRAEDTAMYYCAKGAGPTWWYALDAWGQGTLVTVSS	DIQLTQSPSSVSVSVGERVTIDCKSSQSVLSASNTYLNWYQQKPGQAPQLLIYYASTRESGVPDRFSGSGSGTDFTLTISSLQAEDAAVYYCQQAYRAPVTFGQGTKLEIK	81.04227	0.6515	-0.9347025033116596	0.6675885	0.7922297297297297	0.895	7114.1640589536255	2	4	10	16	0.9162790697674412	0.8325581395348832	0.6883720930232556	0.6372093023255814	0.6572241464621458	0.5909615701797782	0.4723321787893776	0.5027214250371103
Lifastuzumab	18.0	Humanized	https://clincancerres.aacrjournals.org/content/early/2019/09/20/1078-0432.CCR-18-3965.full-text.pdf	EVQLVESGGGLVQPGGSLRLSCAASGFSFSDFAMSWVRQAPGKGLEWVATIGRVAFHTYYPDSMKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHRGFDVGHFDFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSETLVHSSGNTYLEWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSFNPLTFGQGTKVEIK	80.87652	0.565	-1.7255333557450632	0.59610826	0.7970238095238096	0.835	6891.782488163186	6	7	16	17	0.8379629629629635	0.7824074074074079	0.6342592592592594	0.6296296296296298	0.4391252955082774	0.4905109009718948	0.283884948778566	0.48075912792224895
Ligelizumab	6.3	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278557/	QVQLVQSGAEVMKPGSSVKVSCKASGYTFSWYWLEWVRQAPGHGLEWMGEIDPGTFTTNYNEKFKARVTFTADTSTSTAYMELSSLRSEDTAVYYCARFSHFSGSNYDYFDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCRASQSIGTNIHWYQQKPGQAPRLLIYYASESISGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQSWSWPTTFGGGTKVEIK	79.822535	-0.09000000000000001	-1.9716460210117959	1.0483618	0.8026745688017628	0.8600000000000001	6777.311426114877	9	15	17	17	0.7570093457943914	0.6728971962616814	0.5981308411214952	0.5841121495327102	0.12979717637701202	0.144462119705705	0.2080102074633788	0.31412805726784626
Lintuzumab	0.0	Humanized	https://ascopubs.org/doi/full/10.1200/JCO.2005.09.133?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEWIGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVYYCARGRPAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKAPKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQSKEVPWTFGQGTKVEIK	91.894385	-0.186	-1.697870141182869	0.6638589	0.8111602982292637	0.748	6770.35531639063	7	8	8	9	0.7962085308056881	0.7345971563981051	0.6729857819905217	0.6540284360189575	0.23147961413062007	0.31945144701018946	0.4224647910994603	0.5458051830190586
Loncastuximab	0.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013258/	QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQAPGQGLEWIGEIDPSDSYTNYNQNFQGKAKLTVDKSTSTAYMEVSSLRSDDTAVYYCARGSNPYYYAMDYWGQGTSVTVSS	EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWIYDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYTFGGGTKLEIK	81.146185	-1.4015	-3.319259987306248	1.0836477	0.7051282051282051	0.21250000000000002	5433.567105165972	6	12	15	15	0.7067307692307692	0.5	0.3701923076923077	0.2932692307692307	0.0632842334969994	0.0390070921985815	0.0745021822149481	0.07740043644298958
Lorvotuzumab	0.0	Humanized	https://ashpublications.org/blood/article/120/21/728/87502/Phase-I-Study-of-Lorvotuzumab-Mertansine-LM	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSFGMHWVRQAPGKGLEWVAYISSGSFTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARMRKGYAMDYWGQGTLVTVSS	DVVMTQSPLSLPVTLGQPASISCRSSQIIIHSDGNTYLEWFQQRPGQSPRRLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPHTFGQGTKVEIK	88.48786999999999	-0.16449999999999998	-0.3769869833406835	0.37210387	0.8917978208232444	0.9545	8066.954921155513	7	9	12	16	0.8785046728971955	0.8411214953271022	0.7523364485981306	0.7429906542056074	0.5540034466759438	0.6058195797706618	0.6106416119838269	0.6982170080201497
Lutikizumab	16.8	Humanized	"https://ard.bmj.com/content/annrheumdis/78/3/413.full.pdf
https://onlinelibrary.wiley.com/doi/full/10.1002/art.40840"	EVQLVESGGGVVQPGRSLRLSCSASGFIFSRYDMSWVRQAPGKGLEWVAYISHGGAGTYYPDSVKGRFTISRDNSKNTLFLQMDSLRPEDTGVYFCARGGVTKGYFDVWGQGTPVTVSS	DIQMTQSPSSLSASVGDRVTITCRASGNIHNYLTWYQQTPGKAPKLLIYNAKTLADGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQHFWSIPYTFGQGTKLQIT	80.41412	0.08849999999999997	-1.8630166365253251	0.6988928	0.7972983585957747	0.761	6870.293811671828	7	11	15	19	0.8190476190476181	0.7619047619047611	0.6428571428571425	0.5714285714285713	0.3353596757852028	0.43414387031408075	0.3057244174265438	0.2849544072948325
Matuzumab	10.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSHWMHWVRQAPGQGLEWIGEFNPSNGRTNYNEKFKSKATMTVDTSTNTAYMELSSLRSEDTAVYYCASRDYDYDGRYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCSASSSVTYMYWYQQKPGKAPKLLIYDTSNLASGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQWSSHIFTFGQGTKVEIK	79.44667	-0.3065	-1.0603800657717792	0.68336314	0.8123733042257915	0.7204999999999999	7150.855584399177	5	6	11	11	0.791469194312797	0.739336492890996	0.6208530805687205	0.6161137440758294	0.217194380020842	0.34718160734093434	0.25698295855601505	0.42495210245033793
Mavrilimumab	3.1	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767745/	QVQLVQSGAEVKKPGASVKVSCKVSGYTLTELSIHWVRQAPGKGLEWMGGFDPEENEIVYAQRFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCAIVGSFSPLTLGLWGQGTMVTVSS	QSVLTQPPSVSGAPGQRVTISCTGSGSNIGAPYDVSWYQQLPGTAPKLLIYHNNKRPSGVPDRFSGSKSGTSASLAITGLQAEDEADYYCATVEAGLSGSVFGGGTKLTVL	84.96260000000001	-0.15600000000000003	-0.3711687333662557	0.48651418	0.8529279279279279	1.0	7428.513196145301	4	5	6	9	0.8790697674418599	0.809302325581395	0.7720930232558137	0.7255813953488371	0.5557067458353936	0.5498103249216553	0.6502144153059537	0.6669140689427674
Mepolizumab	13.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125526s004lbl.pdf	QVTLRESGPALVKPTQTLTLTCTVSGFSLTSYSVHWVRQPPGKGLEWLGVIWASGGTDYNSALMSRLSISKDTSRNQVVLTMTNMDPVDTATYYCARDPPSSLLRLDYWGRGTPVTVSS	DIVMTQSPDSLAVSLGERATINCKSSQSLLNSGNQKNYLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNVHSFPFTFGGGTKLEIK	79.54442	-0.9285	-1.0418484965557289	0.72476274	0.8040455120101138	0.7625	6601.263931552943	13	16	16	18	0.7962962962962971	0.745370370370371	0.6620370370370373	0.6342592592592594	0.231744155503023	0.36249014972419347	0.38169818754925267	0.494352508536906
Modotuximab	0.0	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172077/	QVQLQQPGAELVEPGGSVKLSCKASGYTFTSHWMHWVKQRPGQGLEWIGEINPSSGRNNYNEKFKSKATLTVDKSSSTAYMQFSSLTSEDSAVYYCVRYYGYDEAMDYWGQGTSVTVSS	DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPYTFGGGTKLEIK	75.45697	-1.8035	-3.2489084752536064	1.3337803	0.7253151260504203	0.0	5098.553175675865	14	21	29	29	0.609302325581395	0.4837209302325579	0.3674418604651162	0.3441860465116279	0.008741547088899754	0.03323437242289283	0.07265380174830927	0.09797130133597223
Mogamulizumab	4.2	Humanized	https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0815-6	EVQLVESGGDLVQPGRSLRLSCAASGFIFSNYGMSWVRQAPGKGLEWVATISSASTYSYYPDSVKGRFTISRDNAKNSLYLQMNSLRVEDTALYYCGRHSDGNFAFGYWGQGTLVTVSS	DVLMTQSPLSLPVTPGEPASISCRSSRNIVHINGDTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSLLPWTFGQGTKVEIK	80.90212	-0.583	-1.678184080526993	0.6082715	0.8143382352941178	0.776	7006.815494602346	5	7	10	17	0.8372093023255809	0.7813953488372088	0.7209302325581393	0.6790697674418603	0.4343146956951971	0.48853702787398884	0.5395431304634664	0.5926521523998017
Motavizumab	1.5	Humanized	https://www.nature.com/articles/pr2011155	QVTLRESGPALVKPTQTLTLTCTFSGFSLSTAGMSVGWIRQPPGKALEWLADIWWDDKKHYNPSLKDRLTISKDTSKNQVVLKVTNMDPADTATYYCARDMIFNFYFDVWGQGTTVTVSS	DIQMTQSPSTLSASVGDRVTITCSASSRVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKVEIK	80.344485	-1.0115	-1.2176652990621664	0.74138796	0.8275943396226415	0.877	6966.854361086491	6	8	14	14	0.7809523809523804	0.7142857142857139	0.5619047619047619	0.5571428571428572	0.193515704154001	0.24062816616007973	0.16624451198919274	0.25354609929078015
Moxetumomab	59.0	Mouse	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323103/	EVQLVESGGGLVKPGGSLKLSCAASGFAFSIYDMSWVRQTPEKCLEWVAYISSGGGTTYYPDTVKGRFTISRDNAKNTLYLQMSSLKSEDTAMYYCARHSGYGTHWGVLFAYWGQGTLVTVSA	DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSILHSGVPSRFSGSGSGTDYSLTISNLEQEDFATYFCQQGNTLPWTFGCGTKLEI	74.79628500000001	-0.39649999999999996	-1.9148314516325142	0.9225978	0.7384951679705476	0.0085	5571.925663766534	9	14	21	25	0.8028169014084503	0.6431924882629105	0.5023474178403757	0.3990610328638498	0.2553940665268187	0.11630539739619727	0.12317284320580692	0.1223404255319148
MuromonabCD3	56.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS	QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN	66.04462	-1.883	-3.592003601674286	1.2806395	0.6558585698430315	0.0025	4692.224495275552	9	11	19	19	0.5789473684210528	0.3732057416267943	0.1483253588516746	0.1196172248803828	0.0035460992907801	0.0035460992907801	0.0014761274559706168	0.006956462723539918
Namilumab	0.9	Human	https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-019-1879-x	QVQLVQSGAEVKKPGASVKVSCKAFGYPFTDYLLHWVRQAPGQGLEWVGWLNPYSGDTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCTRTTLISVYFDYWGQGTMVTVSS	DIQMTQSPSSVSASVGDRVTIACRASQNIRNILNWYQQRPGKAPQLLIYAASNLQSGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSYSMPRTFGGGTKLEIK	86.50937	-0.319	-0.3652969588999838	0.60517085	0.8631508678237649	1.0	8141.996768959186	3	7	8	12	0.9428571428571425	0.8571428571428568	0.7523809523809523	0.7047619047619047	0.7373353596757837	0.6370314083080038	0.6106889564336372	0.6361870989530563
Naptumomab	72.5	Mouse	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360042/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734423/"	EVQLQQSGPDLVKPGASVKISCKASGYSFTGYYMHWVKQSPGKGLEWIGRINPNNGVTLYNQKFKDKATLTVDKSSTTAYMELRSLTSEDSAVYYCARSTMITNYVMDYWGQGTSVTVSS	SIVMTQTPTSLLVSAGDRVTITCKASQSVSNDVAWYQQKPGQSPKLLISYTSSRYAGVPDRFSGSGYGTDFTLTISSVQAEDAAVYFCQQDYNSPPTFGGGTKLEIK	70.45817	-1.006	-2.6823627018990353	1.2830534	0.6791277258566978	0.05	5620.468797222763	12	18	22	25	0.7677725118483414	0.6255924170616115	0.4028436018957345	0.3601895734597156	0.1564065073442915	0.09892944774965558	0.08686262646633709	0.10116466673389121
Natalizumab	9.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLVQSGAEVKKPGASVKVSCKASGFNIKDTYIHWVRQAPGQRLEWMGRIDPANGYTKYDPKFQGRVTITADTSASTAYMELSSLRSEDTAVYYCAREGYYGNYGVYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKTSQDINKYMAWYQQTPGKAPRLLIHYTSALQPGIPSRFSGSGSGRDYTFTISSLQPEDIATYYCLQYDNLWTFGQGTKVEIK	89.00878499999999	-0.7115	-0.9839169770769737	0.6856108	0.7918392391471085	0.7244999999999999	6483.67083529039	7	11	13	14	0.7887323943661966	0.7042253521126755	0.5962441314553987	0.5586854460093895	0.21006892418339693	0.2074967535710697	0.20499950054939506	0.2554606599407317
Navicixizumab	29.0	Humanized/Chimeric	https://link.springer.com/article/10.1007%2Fs10637-018-0665-y	QVQLVQSGAEVKKPGASVKISCKASGYSFTAYYIHWVKQAPGQGLEWIGYISNYNRATNYNQKFKGRVTFTTDTSTSTAYMELRSLRSDDTAVYYCARDYDYDVGMDYWGQGTLVTVSS	DIVMTQSPDSLAVSLGERATISCRASESVDNYGISFMKWFQQKPGQPPKLLIYAASNQGSGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQSKEVPWTFGGGTKVEIK	78.45397	-0.47050000000000003	-2.284373973109031	0.6458801	0.795253236429707	0.63	6502.503898223076	12	17	21	22	0.8224299065420544	0.728971962616821	0.598130841121495	0.5607476635514018	0.35205806323323924	0.2890899449857444	0.20801020746337848	0.258948101014118
Necitumumab	4.1	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQESGPGLVKPSQTLSLTCTVSGGSISSGDYYWSWIRQPPGKGLEWIGYIYYSGSTDYNPSLKSRVTMSVDTSKNQFSLKVNSVTAADTAVYYCARVSIFGVGTFDYWGQGTLVTVSS	EIVMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCHQYGSTPLTFGGGTKAEIK	92.07487	0.5055000000000001	0.5296317498144422	0.31430563	0.9130300455704023	0.9975	9687.140013355369	0	0	2	5	0.9811320754716988	0.9622641509433968	0.9339622641509436	0.8915094339622642	0.9256322761943028	0.9325237521744965	0.9492171818546772	0.9347651545564031
Netakimab	0.0	Chimeric	https://www.researchgate.net/publication/339210970_Primary_efficacy_of_netakimab_a_novel_interleukin-17_inhibitor_in_the_treatment_of_active_ankylosing_spondylitis_in_adults	QVQLVQSGGGLVQAGGSLRLSCAASGGTFATSPMGWLRQAPGKGTEFVAAISPSGGDRIYADSVKGRFTISRDNAGYFIYLQMNSLKPEDTAVYYCAVRRRFDGTSYYTGDYDSWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYSYSPVTFGQGTKVEIK	83.039185	0.45699999999999996	-0.6974078475466214	1.1484369	0.8162222222222222	0.99	7197.543803914916	8	11	14	15	0.7972350230414741	0.7142857142857139	0.6682027649769583	0.640552995391705	0.23457365101153516	0.24062816616007973	0.4046556851978943	0.5121090302970875
Nirsevimab	28.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133204/	QVQLVQSGAEVKKPGSSVMVSCQASGGLLEDYIINWVRQAPGQGPEWMGGIIPVLGTVHYGPKFQGRVTITADESTDTAYMELSSLRSEDTAMYYCATETALVVSETYLPHYFDNWGQGTLVTVSS	DIQMTQSPSSLSAAVGDRVTITCQASQDIVNYLNWYQQKPGKAPKLLIYVASNLETGVPSRFSGSGSGTDFSLTISSLQPEDVATYYCQQYDNLPLTFGGGTKVEIK	83.54572	-0.42	-0.3237215144432809	0.8481136	0.8356326954457796	1.0	7129.0316064464405	8	8	9	12	0.8433179723502298	0.8248847926267275	0.7096774193548385	0.6774193548387096	0.45918717521325475	0.5778099160048361	0.5224204987417065	0.5903111416151909
Nivolumab	7.7	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSKRYYADSVKGRFTISRDNSKNTLFLQMNSLRAEDTAVYYCATNDDYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK	98.73998499999999	1.032	-0.12515596975169352	0.44565064	0.9326358448432719	1.0	9088.128521557372	0	3	5	6	0.9656862745098034	0.9264705882352937	0.8725490196078429	0.8137254901960784	0.8299262967598368	0.8020442219440959	0.7944305381727155	0.7984981226533167
Obexelimab	17.5	Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS	DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK	72.241085	-0.032999999999999974	-2.3884235344048546	0.6999404	0.7125147579693034	0.4025	6210.728592182642	9	13	15	21	0.7926267281105984	0.7419354838709672	0.6543778801843316	0.5852534562211982	0.2206834003333641	0.35518188057652605	0.3491927313135269	0.3171634473968035
Obiltoxaximab	2.5	Chimeric	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125509lbl.pdf	QVQLQQSGPELKKPGASVKVSCKDSGYAFSSSWMNWVRQAPGQGLEWIGRIYPGDGDTNYNGKFQGRVTITADKSSSTAYMELSSLRSEDTAVYFCARSGLLRYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDIRNYLNWYQQKPGKAVKLLIYYTSRLLPGVPSRFSGSGSGTDYSLTISSQEQEDIGTYFCQQGNTLPWTFGQGTKVEIR	77.192935	-0.5645	-2.0956227247833477	0.8055735	0.7753475221864446	0.5465	6652.007037942156	14	17	19	20	0.7619047619047614	0.6571428571428567	0.5857142857142855	0.4952380952380952	0.13872002701789804	0.1299392097264432	0.1912360688956432	0.1783181357649442
Obinutuzumab	6.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLVQSGAEVKKPGSSVKVSCKASGYAFSYSWINWVRQAPGQGLEWMGRIFPGDGDTDYNGKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCARNVFDGYWLVYWGQGTLVTVSS	DIVMTQTPLSLPVTPGEPASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLVSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCAQNLELPYTFGGGTKVEIK	83.72772	-0.8945000000000001	-1.6395015037414886	0.78536236	0.8321953781512605	0.696	7068.220793317324	10	15	19	23	0.7674418604651161	0.7069767441860463	0.6511627906976744	0.627906976744186	0.15540986310407348	0.2167656275771064	0.3349414481279888	0.4737341250206167
Ocaratuzumab	1.0	Humanized	https://n.neurology.org/content/86/16_Supplement/P2.087	EVQLVQSGAEVKKPGESLKISCKGSGRTFTSYNMHWVRQMPGKGLEWMGAIYPLTGDTSYNQKSKLQVTISADKSISTAYLQWSSLKASDTAMYYCARSTYVGGDWQFDVWGKGTTVTVSS	EIVLTQSPGTLSLSPGERATLSCRASSSVPYIHWYQQKPGQAPRLLIYATSALASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQWLSNPPTFGQGTKLEIK	80.65262	-0.07800000000000001	-1.0189814155464347	0.9131375	0.822392016217059	0.8575	6768.657253251469	4	9	13	16	0.7298578199052141	0.668246445497631	0.6161137440758298	0.5592417061611374	0.09913952472185898	0.13736513058384628	0.24567241437262693	0.25615105374609254
Ocrelizumab	1.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf	EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYNMHWVRQAPGKGLEWVGAIYPGNGDTSYNQKFKGRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARVVYYSNSYWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASSSVSYMHWYQQKPGKAPKPLIYAPSNLASGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQWSFNPPTFGQGTKVEIK	80.701235	0.8320000000000001	-1.4640906753900744	0.8563866	0.8233065264460253	0.821	7494.373078064451	8	10	10	15	0.797169811320756	0.7358490566037748	0.6650943396226422	0.5896226415094341	0.23437709086043482	0.32677639502208616	0.39308176100629205	0.32878362103572895
Ofatumumab	0.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGRSLRLSCAASGFTFNDYAMHWVRQAPGKGLEWVSTISWNSGSIGYADSVKGRFTISRDNAKKSLYLQMNSLRAEDTALYYCAKDIQYGNYYYGMDVWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPITFGQGTRLEIK	94.915685	0.91	0.9195971452678504	0.31198192	0.957867320361575	0.9975	10241.726161416373	0	0	2	3	0.9765258215962436	0.9671361502347413	0.9342723004694833	0.924882629107981	0.894957213731558	0.9437535377751131	0.9498218626177864	0.9731961509006753
Olaratumab	3.5	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QLQLQESGPGLVKPSETLSLTCTVSGGSINSSSYYWGWLRQSPGKGLEWIGSFFYTGSTYYNPSLRSRLTISVDTSKNQFSLMLSSVTAADTAVYYCARQSTYYYGSGNYYGWFDRWDQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPAFGQGTKVEIK	90.84212	0.1385	0.36920223741091956	0.61950636	0.8868202222385753	1.0	8578.757930473841	0	1	5	8	0.9678899082568801	0.91743119266055	0.8623853211009171	0.8119266055045872	0.838912746437632	0.7814106317912676	0.7795562495933369	0.795627561975405
Olokizumab	9.8	Humanized	https://www.researchgate.net/publication/260914567_Efficacy_and_safety_of_olokizumab_in_patients_with_rheumatoid_arthritis_with_an_inadequate_response_to_TNF_inhibitor_therapy_Outcomes_of_a_randomised_Phase_IIb_study	EVQLVESGGGLVQPGGSLRLSCAASGFNFNDYFMNWVRQAPGKGLEWVAQMRNKNYQYGTYYAESLEGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARESYYGFTSYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCQASQDIGISLSWYQQKPGKAPKLLIYNANNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCLQHNSAPYTFGQGTKLEIK	82.11182	0.349	-0.8627579014355071	0.7874174	0.8299065420560747	0.8255	7280.228290652872	6	9	11	12	0.8341232227488162	0.7488151658767781	0.6682464454976306	0.6398104265402844	0.41461631541797556	0.36981950186548523	0.40481832543443974	0.5101005008235019
Omalizumab	0.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAVSGYSITSGYSWNWIRQAPGKGLEWVASITYDGSTNYNPSVKGRITISRDDSKNTFYLQMNSLRAEDTAVYYCARGSHYFGHWHFAVWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTITCRASQSVDYDGDSYMNWYQQKPGKAPKLLIYAASYLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSHEDPYTFGQGTKVEIK	80.89872	0.713	-1.194529237678113	0.88085234	0.7960687960687961	0.8595	6888.580698604452	1	3	10	14	0.8472222222222229	0.796296296296297	0.6481481481481485	0.587962962962963	0.46749408983451674	0.5198318886262163	0.3235487260309967	0.32436958234830593
Onartuzumab	11.9	Humanized	https://clincancerres.aacrjournals.org/content/20/6/1666.long	EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYWLHWVRQAPGKGLEWVGMIDPSNSDTRFNPNFKDRFTISADTSKNTAYLQMNSLRAEDTAVYYCATYRSYVTPLDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKSSQSLLYTSSQKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYAYPWTFGQGTKVEIK	78.95761999999999	0.6779999999999999	-2.1485880526567627	0.93390346	0.7812523239384249	0.7275	7091.295164692049	7	9	13	15	0.8564814814814821	0.7916666666666673	0.6666666666666669	0.638888888888889	0.48949303913843073	0.5091607565011835	0.3989361702127666	0.5074862096138693
Ontuxizumab	4.5	Humanized/Chimeric	"https://link.springer.com/article/10.1007%2Fs10637-017-0530-4
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736902/"	QVQLQESGPGLVRPSQTLSLTCTASGYTFTDYVIHWVKQPPGRGLEWIGYINPYDDDTTYNQKFKGRVTMLVDTSSNTAYLRLSSVTAEDTAVYYCARRGNSYDGYFDYSMDYWGSGTPVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQNVGTAVAWLQQTPGKAPKLLIYSASNRYTGVPSRFSGSGSGTDYTFTISSLQPEDIATYYCQQYTNYPMYTFGQGTKVQIK	72.55157	-0.471	-2.328355961416116	1.2595263	0.7219235364396654	0.6505	5813.6904094360025	8	13	18	21	0.7175925925925932	0.6250000000000006	0.5000000000000001	0.4768518518518519	0.0831034935644879	0.0984042553191494	0.1223404255319148	0.16863672182821118
Opicinumab	3.6	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202679/	EVQLLESGGGLVQPGGSLRLSCAASGFTFSAYEMKWVRQAPGKGLEWVSVIGPSGGFTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATEGDNDAFDIWGQGTTVTVSS	DIQMTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPMYTFGQGTKLEIK	91.73972	1.21	0.3164952224798417	0.49714294	0.9129001883239172	1.0	9512.044791852311	1	4	6	6	0.9476190476190474	0.895238095238095	0.8619047619047618	0.8571428571428571	0.7575987841945276	0.7290611279972979	0.7789598108747046	0.8882978723404253
Oportuzumab	40.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVQSGPGLVQPGGSVRISCAASGYTFTNYGMNWVKQAPGKGLEWMGWINTYTGESTYADSFKGRFTFSLDTSASAAYLQINSLRAEDTAVYYCARFAIKGDYWGQGTLLTVSS	DIQMTQSPSSLSASVGDRVTITCRSTKSLLHSNGITYLYWYQQKPGKAPKLLIYQMSNLASGVPSRFSSSGSGTDFTLTISSLQPEDFATYYCAQNLEIPRTFGQGTKVELK	88.13192000000001	-0.14049999999999999	-1.8807293268282268	1.0079031	0.7590825123152709	0.621	6041.211418082125	12	17	24	25	0.8066037735849068	0.660377358490567	0.509433962264151	0.4528301886792453	0.2721798474508279	0.13317944600562073	0.1256858022213301	0.1499397832195905
Otlertuzumab	5.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938145/	EVQLVQSGAEVKKPGESLKISCKGSGYSFTGYNMNWVRQMPGKGLEWMGNIDPYYGGTTYNRKFKGQVTISADKSISTAYLQWSSLKASDTAMYYCARSVGPFDSWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASENVYSYLAWYQQKPGQAPRLLIYFAKTLAEGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHHSDNPWTFGQGTKVEIK	93.599785	0.047	-1.1636748260820995	0.61871064	0.853045439896874	0.8975	7517.588705467162	7	8	12	15	0.797101449275363	0.7439613526570054	0.6570048309178745	0.6231884057971014	0.23417103504985273	0.35949223969575606	0.36083701647994004	0.4544917257683213
Ozanezumab	2.5	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026380/#pone.0097803.s001	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWMHWVRQAPGQGLEWIGNINPSNGGTNYNEKFKSKATMTRDTSTSTAYMELSSLRSEDTAVYYCELMQGYWGQGTLVTVSS	DIVMTQSPLSNPVTLGQPVSISCRSSKSLLYKDGKTYLNWFLQRPGQSPQLLIYLMSTRASGVPDRFSGGGSGTDFTLKISRVEAEDVGVYYCQQLVEYPLTFGQGTKLEIK	90.493785	-1.285	-1.9146326035510053	0.6174228	0.8221396965865992	0.608	6609.854091786293	5	12	15	21	0.7607655502392352	0.6794258373205748	0.6363636363636368	0.5502392344497609	0.13528623299060247	0.15835284536292524	0.2883623468729861	0.24497777325324918
Palivizumab	1.1	Humanized	"https://www.ema.europa.eu/en/documents/product-information/synagis-epar-product-information_en.pdf
https://www.drugsincontext.com/safety-pharmacokinetics-extended-use-palivizumab-saudi-arabian-infants-children/"	QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMSVGWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS	DIQMTQSPSTLSASVGDRVTITCKCQLSVGYMHWYQQKPGKAPKLLIYDTSKLASGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCFQGSGYPFTFGGGTKLEIK	80.06108499999999	-1.147	-1.372462737281701	0.6435332	0.8223270440251573	0.8805	6757.727335339163	5	6	11	13	0.766666666666666	0.7190476190476186	0.5809523809523809	0.5714285714285714	0.15307328605200743	0.25582573454913726	0.187014522120905	0.2849544072948327
Pamrevlumab	0.0	Human	https://www.sciencedirect.com/science/article/pii/S2213260019302620	EGQLVQSGGGLVHPGGSLRLSCAGSGFTFSSYGMHWVRQAPGKGLEWVSGIGTGGGTYSTDSVKGRFTISRDNAKNSLYLQMNSLRAEDMAVYYCARGDYYGSGSFFDCWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNSYPPTFGQGTKLEIK	88.75678500000001	0.8734999999999999	-0.2083953774410609	0.5776477	0.923481308411215	0.9975	8691.132770530894	0	0	0	0	0.9810426540284368	0.9383886255924178	0.8862559241706164	0.8483412322274881	0.9252041948169847	0.8373416019629614	0.8335770226210895	0.8682145137978555
Panitumumab	2.8	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881252/#R77	QVQLQESGPGLVKPSETLSLTCTVSGGSVSSGDYYWTWIRQSPGKGLEWIGHIYYSGNTNYNPSLKSRLTISIDTSKTQFSLKLSSVTAADTAIYYCVRDRVTGAFDIWGQGTMVTVSS	DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQHFDHLPLAFGGGTKVEIK	89.79137	-0.192	0.15622618182253273	0.44985202	0.9042645095421347	1.0	9014.974237988186	2	5	6	10	0.9571428571428565	0.9238095238095233	0.8809523809523806	0.7619047619047619	0.7955927051671708	0.79449510300574	0.8138297872340412	0.716903073286052
PankoMab	25.0	Mouse	https://www.sciencedirect.com/science/article/pii/S1046202305000113#fig1	EVQLVESGGGLVQPGGSMRLSCVASGFPFSNYWMNWVRQAPGKGLEWVGEIRLKSNNYTTHYAESVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCTRHYYFDYWGQGTLVTVSS	DIVMTQSPLSNPVTPGEPASISCRSSKSLLHSNGITYFFWYLQKPGQSPQLLIYQMSNLASGVPDRFSGSGSGTDFTLRISRVEAEDVGVYYCAQNLELPPTFGQGTKVEIK	93.886635	-0.5065	-1.0396066496938554	0.66937566	0.8559218559218559	0.6739999999999999	6935.712294561877	12	13	17	22	0.7699530516431917	0.7417840375586848	0.685446009389671	0.6150234741784038	0.1629790563713227	0.3548596543801805	0.4640312323111236	0.4203126560783138
Parsatuzumab	4.7	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388369/	EVQLVESGGGLVQPGGSLRLSCAASGYTFIDYYMNWVRQAPGKGLEWVGDINLDNSGTHYNQKFKGRFTISRDKSKNTAYLQMNSLRAEDTAVYYCAREGVYHDYDDYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRTSQSLVHINAITYLHWYQQKPGKAPKLLIYRVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCGQSTHVPLTFGQGTKVEIK	78.77077	0.58	-1.6852373273458725	0.9231739	0.7802337398373984	0.817	6479.118269663132	8	8	19	20	0.7990867579908665	0.7534246575342456	0.6210045662100454	0.5799086757990868	0.24015512160367566	0.3917711065772801	0.2572784092749112	0.30299718255124847
Pateclizumab	4.7	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243296/	EVQLVESGGGLVQPGGSLRLSCAASGYTFTSYVIHWVRQAPGKGLEWVGYNNPYNAGTNYNEKFKGRFTISSDKSKNTAYLQMNSLRAEDTAVYYCSRPTMLPWFAYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQAVSSAVAWYQQKPGKAPKLLIYSASHRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQESYSTPWTFGQGTKVEIK	82.88522	0.6815	-1.5823199354344228	0.9373441	0.8121336923808016	0.826	7102.597262414294	5	5	12	16	0.8086124401913884	0.7799043062200964	0.6889952153110052	0.6267942583732058	0.2810835114866512	0.48552716413858843	0.47409990159150406	0.46919644372052
Pembrolizumab	1.7	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCRASKGVSTSGYSYLHWYQQKPGQAPRLLIYLASYLESGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQHSRDLPLTFGGGTKVEIK	79.22807	-0.34	-1.5160418537928473	0.88083404	0.7890765765765766	0.875	6543.46426041355	4	11	15	19	0.8325581395348831	0.720930232558139	0.5953488372093021	0.5534883720930232	0.40462642256308384	0.26199901039089396	0.20357083951838986	0.24901039089559607
Pertuzumab	2.8	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRQAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQQKPGKAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIK	83.14192	0.6950000000000001	-1.7995417444196562	0.8024264	0.8029136888400219	0.8815	7316.551336402668	5	8	13	15	0.8380952380952373	0.7285714285714281	0.6476190476190474	0.6095238095238095	0.4399696048632173	0.2877406281661583	0.32176629517054983	0.39741641337386
Pexelizumab	0.0	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYAQKFQGRVTMTADTSTSTAYMELSSLRSEDTAVYYCARYFFGSSPNWYFVWGQGT	DIQMTQSPSLSASVGDRVTITCGASENIYGALNWYQRKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK	80.73032	-0.389	-1.62317930985864	0.69658166	0.8056603773584906	0.9055	6945.628550573119	8	12	18	20	0.7853658536585367	0.702439024390244	0.6146341463414634	0.5804878048780487	0.20290607161390783	0.20147898287493526	0.24199965403909351	0.30448884276076793
Pinatuzumab	1.4	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035878/	EVQLVESGGGLVQPGGSLRLSCAASGYEFSRSWMNWVRQAPGKGLEWVGRIYPGDGDTNYSGKFKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARDGSSWDWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRSSQSIVHSVGNTFLEWYQQKPGKAPKLLIYKVSNRFSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCFQGSQFPYTFGQGTKVEIK	79.61317	0.7	-1.7395496788992726	0.91713166	0.7851190476190477	0.8005	6837.073270797147	3	4	7	11	0.8240740740740745	0.7314814814814818	0.6250000000000001	0.6018518518518519	0.3599290780141863	0.3012214342001595	0.26507092198581583	0.37293144208037815
Polatuzumab	2.6	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVESGGGLVQPGGSLRLSCAASGYTFSSYWIEWVRQAPGKGLEWIGEILPGGGDTNYNEIFKGRATFSADTSKNTAYLQMNSLRAEDTAVYYCTRRVPIRLDYWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTITCKASQSVDYEGDSFLNWYQQKPGKAPKLLIYAASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSNEDPLTFGQGTKVEIK	82.65077	0.6655	-1.5211814033405104	0.9017877	0.8039963039963041	0.7745	7141.733671864012	7	10	12	14	0.773584905660378	0.7028301886792457	0.6650943396226418	0.6415094339622642	0.17329051251171068	0.20279673491235242	0.39308176100628994	0.5146527498996389
Ponezumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651443/	QVQLVQSGAEVKKPGASVKVSCKASGYYTEAYYIHWVRQAPGQGLEWMGRIDPATGNTKYAPRLQDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCASLYSLPVYWGQGTTVTVSS	DVVMTQSPLSLPVTLGQPASISCKSSQSLLYSDAKTYLNWFQQRPGQSPRRLIYQISRLDPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHYPVLFGQGTRLEIK	89.20337	-1.5325	-0.30864935588494496	0.69408345	0.8426724137931034	0.981	6909.667139817932	8	14	15	17	0.8160377358490576	0.7075471698113216	0.6698113207547174	0.6415094339622642	0.3193496587715826	0.2186872741870763	0.4106449886257205	0.5146527498996389
Prasinezumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324684/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYGMSWVRQAPGKGLEWVASISSGGGSTYYPDNVKGRFTISRDDAKNSLYLQMNSLRAEDTAVYYCARGGAGIDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKSIQTLLYSSNQKNYLAWFQQKPGKAPKLLIYWASIRKSGVPSRFSGSGSGTDFTLTISSLQPEDLATYYCQQYYSYPLTFGGGTKLEIK	89.339185	0.608	-1.311606108593581	0.41750434	0.8293790051876717	0.76	7655.982657093074	1	5	10	11	0.9530516431924877	0.8591549295774642	0.7699530516431922	0.732394366197183	0.7796340691905551	0.6391719108980116	0.6452652082709013	0.6802017780441514
Prezalumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032945/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAYIKQDGNEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGILWFGDLPTFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISNWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYDSYPRTFGQGTKVEIK	92.39501999999999	1.0365	0.4885996141500384	0.40318927	0.9187842743492701	0.999	9306.905747622824	2	2	2	5	0.9622641509433969	0.9292452830188684	0.9198113207547174	0.8867924528301888	0.8159708283152709	0.809915696507428	0.9163990365315141	0.9303492573263751
Racotumomab	85.0	Mouse	https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.25631	QVQLQQSGAELVKPGASVKLSCKASGYTFTSYDINWVRQRPEQGLEWIGWIFPGDGSTKYNEKFKGKATLTTDKSSSTAYMQLSRLTSEDSAVYFCAREDYYDNSYYFDYWGQGTTLTVSS	DIQMTQTTSSLSASLGDRVTISCRASQDISNYLNWYQQKPDGTVKLLIYYTSRLHSGVPSRFSGSGSGTDYSLTISNLEQEDIATYFCQQGNTLPWTFGGGTKLEIK	71.87037000000001	-1.096	-2.2658149732271045	1.0890485	0.7080018537112844	0.0	5670.674073259514	3	11	16	19	0.764150943396227	0.5613207547169814	0.3915094339622641	0.2971698113207547	0.14549043222266994	0.07871671350194041	0.08032249431285961	0.07878362103572861
Ramucirumab	4.1	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSYSMNWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARVTDAFDIWGQGTMVTVSS	DIQMTQSPSSVSASIGDRVTITCRASQGIDNWLGWYQQKPGKAPKLLIYDASNLDTGVPSRFSGSGSGTYFTLTISSLQAEDFAVYFCQQAKAFPPTFGGGTKVDIK	92.034385	0.628	0.1360264969023292	0.21325321	0.8986464711569448	0.976	9059.707189634331	1	2	3	3	0.985507246376812	0.9082125603864737	0.8743961352657007	0.8647342995169084	0.946577243293249	0.767850412855039	0.7983605714873064	0.9012659745777232
Ranibizumab	3.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGYDFTHYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPYYYGTSHWYFDVWGQGTLVTVSS	DIQLTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK	80.720085	0.5515000000000001	-1.5379723199535826	0.96954757	0.7969759136843705	0.8595	7235.013015416602	12	16	19	19	0.8317757009345783	0.7102803738317748	0.6214953271028033	0.6028037383177567	0.3996321336249679	0.2278451647113378	0.25823556704447453	0.37596937760986177
Ravulizumab	0.2	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761108s000lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKASGHIFSNYWIQWVRQAPGQGLEWMGEILPGSGHTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK	80.80827	-0.122	-1.6191586332274217	0.6853211	0.801133752106634	0.9339999999999999	7140.208567061355	7	10	15	16	0.7840375586854452	0.6854460093896706	0.6009389671361499	0.5774647887323943	0.20007991209669196	0.1672993040988236	0.21282422668398024	0.29779742283488136
Refanezumab	9.4	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325241/	QVQLVQSGSELKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARNPINYYGINYEGYVMDYWGQGTLVTVSS	DIVMTQSPDSLAVSLGERATINCKSSHSVLYSSNQKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCHQYLSSLTFGQGTKLEIK	89.424785	-0.28200000000000003	0.13547991296318906	0.5973517	0.8893849206349207	0.94	7978.076984874361	3	7	12	20	0.8963963963963957	0.8243243243243237	0.7297297297297294	0.653153153153153	0.5993546738227575	0.5768161778800065	0.5613858539390446	0.5439428790492618
Reslizumab	5.0	Humanized	https://www.sciencedirect.com/science/article/pii/S2213219817307079	EVQLVESGGGLVQPGGSLRLSCAVSGLSLTSNSVNWIRQAPGKGLEWVGLIWSNGDTDYNSAIKSRFTISRDTSKSTVYLQMNSLRAEDTAVYYCAREYYGYFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCLASEGISSYLAWYQQKPGKAPKLLIYGANSLQTGVPSRFSGSGSATDYTLTISSLQPEDFATYYCQQSYKFPNTFGQGTKVEVK	81.15742	0.388	-1.1466148546543455	0.715879	0.8182001289075089	0.7755	7435.241351299359	4	9	10	10	0.8260869565217398	0.7439613526570055	0.6714975845410631	0.5942028985507247	0.36956521739130743	0.35949223969575633	0.41692363038339125	0.34543632439099636
Risankizumab	24.0	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761105s000lbl.pdf	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDQTIHWMRQAPGQGLEWIGYIYPRDDSPKYNENFKGKVTITADKSTSTAYMELSSLRSEDTAVYYCAIPDRSGYAWFIYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASRDVAIAVAWYQQKPGKVPKLLIYWASTRHTGVPSRFSGSGSRTDFTLTISSLQPEDVADYFCHQYSSYPFTFGSGTKLEIK	77.06682	-0.5925	-2.30454315960926	0.8898577	0.772196261682243	0.723	6599.878131736877	5	11	16	18	0.7677725118483423	0.6777251184834132	0.5734597156398107	0.5450236966824645	0.15640650734429407	0.1547342946455601	0.17689321367349023	0.23938691136432388
Rituximab	11.0	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA	QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK	67.64497	-1.4965000000000002	-3.242149205411292	1.2812606	0.6643146733198191	0.0	5074.563686507621	10	13	22	26	0.6113744075829382	0.4644549763033172	0.2274881516587677	0.1848341232227488	0.010571073241235216	0.014781015764175771	0.013293670800981398	0.027394037175220945
Robatumumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303167/	EVQLVQSGGGLVKPGGSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWISVIDTRGATYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARLGNFYYGMDVWGQGTTVTVSS	EIVLTQSPGTLSVSPGERATLSCRASQSIGSSLHWYQQKPGQAPRLLIKYASQSLSGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCHQSSRLPHTFGQGTKVEIK	85.95882	0.817	-0.7957115234792531	0.39950418	0.8608031047045779	0.9650000000000001	7806.120473135117	4	4	4	11	0.9282296650717708	0.8995215311004789	0.842105263157895	0.7799043062200958	0.6903271234178304	0.7351369235467786	0.7519596864501686	0.7374868505887545
Roledumab	0.0	Human	https://onlinelibrary.wiley.com/doi/full/10.1111/j.1423-0410.2012.01603.x	QVQLVESGGGVVQPGRSLRLSCTASGFTFKNYAMHWVRQAPAKGLEWVATISYDGRNIQYADSVKGRFTFSRDNSQDTLYLQLNSLRPEDTAVYYCARPVRSRWLQLGLEDAFHIWGQGTMVTVSS	AIRMTQSPSSFSASTGDRVTITCRASQDIRNYVAWYQQKSGKAPKFLIYAASTLQSGVPSRFSGSGSGTDFTLTINSLQSEDFATYYCQQYYNSPPTFGQGTRVEIT	83.20992000000001	0.1285	-0.665964283900391	0.7562542	0.8314048360777333	0.992	6911.496922834775	5	6	15	19	0.9262672811059902	0.8755760368663588	0.7188940092165894	0.6359447004608294	0.6851080171258604	0.6824852109683937	0.5356652613001268	0.49913390201653723
Romosozumab	18.1	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf	EVQLVQSGAEVKKPGASVKVSCKASGYTFTDYNMHWVRQAPGQGLEWMGEINPNSGGAGYNQKFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARLGYDDIYDDWYFDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDISNYLNWYQQKPGKAPKLLIYYTSRLLSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGDTLPYTFGGGTKVEIK	84.96572	0.17049999999999998	-0.8999792713318748	0.7830962	0.8463642580351037	0.788	8240.148324161091	3	6	9	9	0.8738317757009332	0.8130841121495316	0.7289719626168221	0.7056074766355139	0.5399184728574229	0.5568867236693821	0.5595048717438846	0.6373864916815801
Rovalpituzumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277321/	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGMNWVRQAPGQGLEWMGWINTYTGEPTYADDFKGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARIGDSSPSDYWGQGTLVTVSS	EIVMTQSPATLSVSPGERATLSCKASQSVSNDVVWYQQKPGQAPRLLIYYASNRYTGIPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQDYTSPWTFGQGTKLEIK	83.98647	0.014500000000000013	-1.2250861318051143	0.49485585	0.849833676540472	0.9775	8053.370419380183	0	5	8	8	0.9377990430622017	0.8421052631578955	0.7224880382775122	0.6985645933014355	0.7185432149037996	0.6084359835759632	0.5434100240931152	0.627142081509383
Sarilumab	3.8	Human	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761037s000lbl.pdf	EVQLVESGGGLVQPGRSLRLSCAASRFTFDDYAMHWVRQAPGKGLEWVSGISWNSGRIGYADSVKGRFTISRDNAENSLFLQMNGLRAEDTALYYCAKGRDSFDIWGQGTMVTVSS	DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYGASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFASYYCQQANSFPYTFGQGTKLEIK	96.800735	0.6105	0.617177673770951	0.33366534	0.9378424105704157	0.997	9798.71984700651	0	0	0	8	0.9855072463768121	0.9806763285024159	0.9613526570048313	0.8937198067632852	0.9465772432932497	0.9795628190632822	0.9832288347551994	0.9379004351252271
Satumomab	55.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLQQSDAELVKPGASVKISCKASGYTFTDHAIHWAKQKPEQGLEWIGYISPGNDDIKYNEKFKGKATLTADKSSSTAYMQLNSLTSEDSAVYFCKRSYYGHWGQGTTLTVSS	DIQMTQSPASLSVSVGETVTITCRASENIYSNLAWYQQKQGKSPQLLVYAATNLADGVPSRFSGSGSGTQYSLKINSLQSEDFGSYYCQHFWGTPYTFGGGTRLEIK	77.47131999999999	-1.8755	-3.114273625978443	1.3475761	0.6662567634038367	0.0	5291.995080341745	12	15	20	20	0.6243902439024394	0.4731707317073173	0.2341463414634147	0.1804878048780488	0.022833419823559988	0.022227988237329493	0.01565473101539524	0.025082165715274097
Secukinumab	1.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMNWVRQAPGKGLEWVAAINQDGSEKYYVGSVKGRFTISRDNAKNSLYLQMNSLRVEDTAVYYCVRDYYDILTDYYIHYWYFDLWGRGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPCTFGQGTRLEIK	90.84362	0.866	0.6681887967855236	0.49720198	0.9113079615048119	0.995	9148.484136628873	2	6	7	10	0.9680365296803647	0.9178082191780819	0.8904109589041096	0.863013698630137	0.8395106706823385	0.7817448751578739	0.8489021665209365	0.8991304770232198
Setrusumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451251/	QVQLVESGGGLVQPGGSLRLSCAASGFTFRSHWLSWVRQAPGKGLEWVSNINYDGSSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDTYLHFDYWGQGTLVTVSS	DIALTQPASVSGSPGQSITISCTGTSSDVGDINDVSWYQQHPGKAPKLMIYDVNNRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCQSYAGSYLSEVFGGGTKLTVL	87.13367	1.2595	-0.22155575007391598	0.4880614	0.8773388773388773	0.995	8726.651381636948	3	7	13	17	0.8962264150943404	0.8443396226415101	0.7924528301886795	0.759433962264151	0.5990231500066924	0.6143784290111083	0.674160310450957	0.7140372005887863
Sifalimumab	0.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099191/	QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYSISWVRQAPGQGLEWMGWISVYNGNTNYAQKFQGRVTMTTDTSTSTAYLELRSLRSDDTAVYYCARDPIAAGYWGQGTLVTVSS	EIVLTQSPGTLSLSPGERATLSCRASQSVSSTYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPRTFGQGTKVEIK	98.913935	0.522	0.9189686646680195	0.28838548	0.9383780332056194	1.0	10698.866900268851	0	0	0	3	0.9807692307692306	0.9759615384615383	0.971153846153846	0.9615384615384615	0.9238952536824873	0.9672667757774139	0.9897708674304418	0.99645390070922
Siltuximab	0.2	Chimeric	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGKLLKPGGSLKLSCAASGFTFSSFAMSWFRQSPEKRLEWVAEISSGGSYTYYPDTVTGRFTISRDNAKNTLYLEMSSLRSEDTAMYYCARGLWGYYALDYWGQGTSVTVSS	QIVLIQSPAIMSASPGEKVTMTCSASSSVSYMYWYQQKPGSSPRLLIYDTSNLASGVPVRFSGSGSGTSYSLTISRMEAEDAATYYCQQWSGYPYTFGGGTKLEIK	72.16287	-0.7064999999999999	-2.9708831193428447	0.9207606	0.7098858411289044	0.0	5562.83751969046	3	12	21	24	0.7655502392344502	0.5454545454545459	0.3588516746411485	0.3157894736842106	0.14970816790525768	0.07205029013539668	0.06595066001560984	0.08893243747667039
Sirukumab	2.9	Human	https://www.fda.gov/media/106879/download	EVQLVESGGGLVQPGGSLRLSCAASGFTFSPFAMSWVRQAPGKGLEWVAKISPGGSWTYYSDTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARQLWGYYALDIWGQGTTVTVSS	EIVLTQSPATLSLSPGERATLSCSASISVSYMYWYQQKPGQAPRLLIYDMSNLASGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCMQWSGYPYTFGGGTKVEIK	83.31727000000001	0.58	-0.8227684980072669	0.6437406	0.8546456318376408	0.9225000000000001	7517.2525607536445	10	14	20	21	0.8086124401913883	0.7368421052631585	0.6411483253588518	0.6124401913875598	0.2810835114866506	0.3325867861142253	0.2999677627337207	0.40931996335131826
Solanezumab	3.5	Humanized	https://www.sciencedirect.com/science/article/pii/S1552526015021482?via%3Dihub	EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYSMSWVRQAPGKGLELVAQINSVGNSTYYPDTVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCASGDYWGQGTLVTVSS	DVVMTQSPLSLPVTLGQPASISCRSSQSLIYSDGNAYLHWFLQKPGQSPRLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPWTFGQGTKVEIK	94.243785	-0.3015	-0.9138341997193374	0.5002151	0.8883928571428572	0.8714999999999999	7758.895001979617	4	6	8	16	0.9086538461538457	0.8413461538461534	0.7788461538461536	0.7596153846153845	0.6340016366612097	0.6064170758319684	0.665780141843971	0.7141980360065465
Suptavumab	5.0	Human	https://academic.oup.com/ofid/article/2/suppl_1/912/2635143	EVQLVESGGDLVQPGRSLRLSCVASGFTFDDYAMHWVRQAPGKGLEWVSGVSWSGSTVGYADSVKGRFTVSRDNAQKSLYLQMNSLRAEDTALYYCVKDAYKFNYYYYGLDVWGQGTTVTVSS	EIVMTQSPATLSVSPGERATLSCRASQTILSNLAWYLQKPGQAPRLLIYGASTRATGLPARFSGSGSGTEFTLTISSLQSEDFAVYYCQQYNNWPLTFGGGTKVEIK	87.92747	0.3765	0.2957941608171237	0.5456146	0.8941189879188511	1.0	8548.188169162455	2	4	7	8	0.9252336448598123	0.8691588785046724	0.7990654205607474	0.7943925233644857	0.6823589845562386	0.664429641413136	0.6800225359581094	0.7683436070789413
Sutimlimab	8.0	Humanized/Chimeric	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175298/	EVQLVESGGGLVKPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEWVATISSGGSHTYYLDSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCARLFTGYAMDYWGQGTLVTVSS	QIVLTQSPATLSLSPGERATMSCTASSSVSSSYLHWYQQKPGKAPKLWIYSTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCHQYYRLPPITFGQGTKLEIK	81.08172	0.747	-2.3813962369766135	0.48838428	0.8132872026123465	0.755	7414.694004800957	6	10	12	14	0.8909952606635078	0.7772511848341239	0.7061611374407586	0.6777251184834124	0.5888205438472669	0.4775301670532102	0.5155625021007704	0.5907448489126417
Suvratoxumab	3.0	Human	https://aac.asm.org/content/61/1/e01020-16	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSHDMHWVRQATGKGLEWVSGIGTAGDTYYPDSVKGRFTISRENAKNSLYLQMNSLRAGDTAVYYCARDRYSPTGHYYGMDVWGQGTTVTVSS	DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCKQYADYWTFGQGTKVEIK	93.897985	0.7755	0.7223508698879975	0.4015171	0.9360501082585833	1.0	9210.88966830176	0	0	0	1	0.9386792452830197	0.9245283018867932	0.9009433962264157	0.8396226415094342	0.7211963067041374	0.7965341897497682	0.8832128997725157	0.8554462732503688
Tabalumab	4.4	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4623366/	QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGEINHSGSTNYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCARGYYDILTGYYYYFDYWGQGTLVTVSS	EIVLTQSPATLSLSPGERATLSCRASQSVSRYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDSTLTISSLEPEDFAVYYCQQRSNWPRTFGQGTKVEIK	95.31177	0.4315	1.2013519115566331	0.25039583	0.93192006686422	1.0	10312.607274097714	0	0	1	2	0.9999999999999996	0.9999999999999996	0.9859813084112146	0.9626168224299064	0.9999999999999987	0.9999999999999997	0.9939683170941869	0.99645390070922
Tafasitamab	1.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961010/	EVQLVESGGGLVKPGGSLKLSCAASGYTFTSYVMHWVRQAPGKGLEWIGYINPYNDGTKYNEKFQGRVTISSDKSISTAYMELSSLRSEDTAMYYCARGTYYYGTRVFDYWGQGTLVTVSS	DIVMTQSPATLSLSPGERATLSCRSSKSLQNVNGNTYLYWFQQKPGQSPQLLIYRMSNLNSGVPDRFSGSGSGTEFTLTISSLEPEDFAVYYCMQHLEYPITFGAGTKLEIK	72.241085	-0.032999999999999974	-2.3884235344048546	0.6999404	0.7125147579693034	0.4025	6210.728592182642	9	13	15	21	0.7926267281105984	0.7419354838709672	0.6543778801843316	0.5852534562211982	0.2206834003333641	0.35518188057652605	0.3491927313135269	0.3171634473968035
Talacotuzumab	17.5	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	EVQLVQSGAEVKKPGESLKISCKGSGYSFTDYYMKWARQMPGKGLEWMGDIIPSNGATFYNQKFKGQVTISADKSISTTYLQWSSLKASDTAMYYCARSHLLRASWFAYWGQGTMVTVSS	DIVMTQSPDSLAVSLGERATINCESSQSLLNSGNQKNYLTWYQQKPGQPPKPLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQNDYSYPYTFGQGTKLEIK	83.69682	-0.41900000000000004	-0.8907014881144016	0.8493881	0.8388274336283186	0.875	6802.065253849571	14	16	17	20	0.7834101382488475	0.7281105990783406	0.6820276497695851	0.6451612903225806	0.19874497499754798	0.2861881883844809	0.4543337582115888	0.5243651338366506
Tarextumab	26.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647865/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSSGMSWVRQAPGKGLEWVSVIASSGSNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARSIFYTTWGQGTLVTVSS	DIVLTQSPATLSLSPGERATLSCRASQSVRSNYLAWYQQKPGQAPRLLIYGASSRATGVPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYSNFPITFGQGTKVEIK	91.41567	1.376	-0.6393518446797973	0.43763167	0.8971819645732689	0.99	9202.853746975125	2	4	6	10	0.9420289855072469	0.9082125603864738	0.8743961352657007	0.8067632850241546	0.7338112858464404	0.7678504128550395	0.7983605714873064	0.7908315345873163
Temelimab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pubmed/25427053	QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYEMHWVRQAPGQGLEWIGAVAPETGGTAYNQKFKGRATITADKSTSTAYMELSSLRSEDTAVYYCTSTVVPFAYWGQGTLVTVSS	QIQLTQSPSSLSASVGDRVTITCSASSSVSYMYWYQQKPGKAPKAWIYRTSNLASGVPSRFSGSGSGTDYTLTISSLQPEDFATYYCQQYQSLPLTFGGGTKVEIK	90.183285	-0.34149999999999997	-1.881462067843819	0.8050788	0.8073357189329864	0.736	6866.1527453909	4	9	12	13	0.8009708737864076	0.7087378640776698	0.6213592233009708	0.5970873786407767	0.2472113199752112	0.22269847827583808	0.2579701163671416	0.35617640983267884
Tezepelumab	2.1	Human	https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/cpdd.775	QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS	SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL	90.696285	0.614	0.5719843439674075	0.45798504	0.9107468123861566	1.0	7689.90453104959	0	0	1	8	0.9672897196261676	0.9532710280373827	0.9439252336448595	0.9205607476635512	0.8364651686882719	0.899864121429043	0.9658646516868823	0.9655332405382112
Ticilimumab	2.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500167/	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK	94.17243500000001	1.3555	0.6631566601983868	0.23100013	0.9439626168224299	0.9995	10343.366588883806	0	0	0	1	0.9814814814814817	0.9768518518518521	0.9398148148148149	0.9305555555555556	0.927304964539008	0.9697924875229846	0.9606317310218022	0.9826635145784082
Tigatuzumab	0.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883819/	EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYVMSWVRQAPGKGLEWVATISSGGSYTYYPDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCARRGDSMITTDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIK	92.966235	1.0815	-1.1138391141460162	0.48887938	0.8483827493261455	0.8460000000000001	8303.587331469287	0	2	4	5	0.9186602870813404	0.8421052631578952	0.7751196172248805	0.7511961722488039	0.664401574535955	0.6084359835759625	0.6571906070786254	0.7067341952560319
Tildrakizumab	6.5	Humanized	https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf	QVQLVQSGAEVKKPGASVKVSCKASGYIFITYWMTWVRQAPGQGLEWMGQIFPASGSADYNEKFEGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARGGGGFAYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRTSENIYSYLAWYQQKPGKAPKLLIYNAKTLAEGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHHYGIPFTFGQGTKVEIK	92.875485	-0.13099999999999998	-1.9215130061570078	0.5824028	0.8260957138253303	0.7110000000000001	7647.202476705801	7	8	12	15	0.8309178743961358	0.7391304347826092	0.671497584541063	0.6328502415458938	0.39415664508171805	0.34597594819611743	0.4169236303833907	0.4903552951656559
Tocilizumab	2.0	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	QVQLQESGPGLVRPSQTLSLTCTVSGYSITSDHAWSWVRQPPGRGLEWIGYISYSGITTYNPSLKSRVTMLRDTSKNQFSLRLSSVTAADTAVYYCARSLARTTAMDYWGQGSLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDISSYLNWYQQKPGKAPKLLIYYTSRLHSGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQGNTLPYTFGQGTKVEIK	84.70798500000001	0.020500000000000018	-0.5809867272520127	0.6739268	0.8384120003141444	0.7925	7806.980194158716	3	10	12	14	0.9095238095238088	0.809523809523809	0.7333333333333331	0.7047619047619046	0.6367781155015174	0.5503208375548787	0.5715130023640653	0.636187098953056
Tomuzotuximab	12.5	Chimeric	https://esmoopen.bmj.com/content/3/2/e000303	QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVST	DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIKYASESISGIPSRFSGSGSGTDFTLSINSVESEDIADYYCQQNNNWPTTFGAGTKLELK	61.699569999999994	-1.6535000000000002	-3.997097091544892	1.4156561	0.6179612031728579	0.0025	4760.048469204516	6	13	22	25	0.6619047619047618	0.4761904761904761	0.2523809523809524	0.1904761904761905	0.03714961161769656	0.026511313745356164	0.02077001013171217	0.03047956771361028
Toripalimab	1.0	Humanized	https://ard.bmj.com/content/76/6/1078	QGQLVQSGAEVKKPGASVKVSCKASGYTFTDYEMHWVRQAPIHGLEWIGVIESETGGTAYNQKFKGRVTITADKSTSTAYMELSSLRSEDTAVYYCAREGITTVATTYYWYFDVWGQGTTVTVSS	DVVMTQSPLSLPVTLGQPASISCRSSQSIVHSNGNTYLEWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCFQGSHVPLTFGQGTKLEIK	80.91163499999999	-0.96	-1.497236170728998	0.97149974	0.8135	0.771	6755.468696065142	4	6	8	12	0.8190045248868771	0.7466063348416284	0.6651583710407237	0.6199095022624433	0.3351304515259425	0.3651198613651669	0.39332017586085083	0.44110426494656746
Tosatoxumab	2.1	Human	"https://www.sec.gov/Archives/edgar/data/1614067/000104746918005409/a2236377zs-1a.htm 
AR301 - ADA in 1 patient"	EVQMVQSGAEVKKPGEPLKISCKGSGYKFGTHWIGWVRQRPGKGLEWMGIIHPADSETKYSPSFQGQVSFSADKSSNTAYLHWSTLRASDTAMYYCARRSGSSSWYALDFWGQGTMVTVSS	QSVLTQSPSASGTPGQRVTISCSGGSSNIGSNTVNWYQQFPGAAPKLLIYTNNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEADYYCATWDDSLNGLYVFGTGTKVTVL	83.45857000000001	-0.29949999999999993	-0.7391621771904269	0.7039603	0.839252475616112	1.0	7568.344018754337	0	4	7	9	0.9444444444444448	0.8564814814814818	0.6990740740740742	0.662037037037037	0.7440898345153676	0.6363278171788814	0.5010835303388499	0.5628447596532702
Tositumomab	45.5	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGAIYPGNGDTSYNQKFKGKATLTVDKSSSTAYMQLSSLTSEDSAVYFCARVVYYSNSYWYFDVWGTGTTVTVSG	QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYAPSNLASGVPARFSGSGSGTSYSLTISRVEAEDAATYYCQQWSFNPPTFGAGTKLELK	65.58682	-1.7295	-3.2917035270699584	1.3683499	0.662155892360037	0.0005	4800.138629707088	15	19	27	31	0.5990566037735849	0.4198113207547169	0.1981132075471698	0.1179245283018868	0.006757660912618693	0.0035460992907801	0.0035460992907801	0.00635621570988886
Tovetumab	2.9	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209236/	QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMNWIRQAPGKGLEWVSYISSSGSIIYYADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAREGRIAARGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVSITCRPSQSFSRYINWYQQKPGKAPKLLIHAASSLVGGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTYSNPPITFGQGTRLEMK	89.14750000000001	0.6809999999999999	0.24922788800822962	0.2678357	0.8898148148148148	1.0	8747.197649664213	2	3	4	7	0.9528301886792465	0.9103773584905671	0.8113207547169815	0.7641509433962265	0.778770239528976	0.7751572327044035	0.6960725277666271	0.719690887193898
Tralokinumab	0.5	Human	https://www.sciencedirect.com/science/article/pii/S0091674918308509	QVQLVQSGAEVKKPGASVKVSCKASGYTFTNYGLSWVRQAPGQGLEWMGWISANNGDTNYGQEFQGRVTMTTDTSTSTAYMELRSLRSDDTAVYYCARDSSSSWARWFFDLWGRGTLVTVSS	SYVLTQPPSVSVAPGKTARITCGGNIIGSKLVHWYQQKPGQAPVLVIYDDGDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTGSDPVVFGGGTKLTVL	88.26282	-0.10550000000000001	-0.21714511517678256	0.39440766	0.89275956284153	1.0	7727.764812898323	1	2	5	6	0.9439252336448584	0.89252336448598	0.7616822429906537	0.7149532710280373	0.7418804268575535	0.7252104460794042	0.6232683767481925	0.6497646980844434
Trastuzumab	8.1	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK	89.552785	0.6935	-1.1931199328971558	0.765754	0.812733644859813	0.871	7489.69105166523	6	8	12	14	0.8199052132701433	0.7535545023696693	0.6445497630331758	0.6066350710900474	0.33992134718161354	0.39250781486337194	0.3114265066720461	0.38819703539376826
Tremelimumab	0.0	Human	https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-236	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDPRGATLYYYYYGMDVWGQGTTVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQSINSYLDWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYSTPFTFGPGTKVEIK	94.17243500000001	1.3555	0.6631566601983868	0.23100013	0.9439626168224299	0.9995	10343.366588883806	0	0	0	1	0.9814814814814817	0.9768518518518521	0.9398148148148149	0.9305555555555556	0.927304964539008	0.9697924875229846	0.9606317310218022	0.9826635145784082
Ublituximab	0.0	Chimeric	https://www.tgtherapeutics.com/EHA2013PosterP111.pdf	QAYLQQSGAELVRPGASVKMSCKASGYTFTSYNMHWVKQTPRQGLEWIGGIYPGNGDTSYNQKFKGKATLTVGKSSSTAYMQLSSLTSEDSAVYFCARYDYNYAMDYWGQGTSVTVSS	QIVLSQSPAILSASPGEKVTMTCRASSSVSYMHWYQQKPGSSPKPWIYATSNLASGVPARFSGSGSGTSYSFTISRVEAEDAATYYCQQWTFNPPTFGGGTRLEIK	66.05001999999999	-1.8005	-3.5939497931074076	1.3100463	0.6602174608250719	0.0025	4852.100931406256	13	16	25	28	0.5913461538461539	0.4615384615384616	0.201923076923077	0.1586538461538462	0.004023458810692814	0.013229678123295096	0.004569012547735951	0.017014457174031647
Ustekinumab	4.0	Human	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062386/#!po=9.61538	EVQLVQSGAEVKKPGESLKISCKGSGYSFTTYWLGWVRQMPGKGLDWIGIMSPVDSDIRYSPSFQGQVTMSVDKSITTAYLQWNSLKASDTAMYYCARRRPGQGYFDFWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNIYPYTFGQGTKLEIK	90.21722	0.07500000000000001	0.40898877650348486	0.5076183	0.9061493756381058	1.0	8976.597681897487	1	1	5	14	0.9333333333333327	0.9142857142857137	0.8428571428571425	0.7666666666666666	0.7050827423167831	0.778622087132725	0.7532928064842952	0.7228132387706855
Utomilumab	40.7	Human	"https://jitc.biomedcentral.com/articles/10.1186/s40425-019-0815-6
https://clincancerres.aacrjournals.org/content/24/8/1816.long"	EVQLVQSGAEVKKPGESLRISCKGSGYSFSTYWISWVRQMPGKGLEWMGKIYPGDSYTNYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARGYGIFDYWGQGTLVTVSS	SYELTQPPSVSVSPGQTASITCSGDNIGDQYAHWYQQKPGQSPVLVIYQDKNRPSGIPERFSGSNSGNTATLTISGTQAMDEADYYCATYTGFGSLAVFGGGTKLTVL	92.550285	0.40299999999999997	0.12895821510604114	0.3790357	0.8871328224776501	0.9975	7675.489504892141	1	1	9	14	0.9134615384615375	0.8749999999999991	0.7451923076923073	0.6730769230769229	0.6487315875613721	0.6808510638297849	0.5996317512274952	0.5841516639388977
Varlilumab	0.0	Human	https://ascopubs.org/doi/full/10.1200/JCO.2016.70.1508?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed	QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYDMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGSGNWGFFDYWGQGTLVTVSS	DIQMTQSPSSLSASVGDRVTITCRASQGISRWLAWYQQKPEKAPKSLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYNTYPRTFGQGTKVEIK	94.43992	1.219	0.843816935688497	0.23023666	0.9430220686405404	1.0	10154.02664407052	0	0	0	0	0.9809523809523807	0.9714285714285712	0.9428571428571427	0.9238095238095237	0.9247720364741632	0.9544072948328263	0.9645390070921984	0.9712934819317797
Vatelizumab	2.6	Humanized	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061540/	QVQLQESGPGLVKPSETLSLTCTVSGFSLTNYGIHWIRQPPGKGLEWLGVIWARGFTNYNSALMSRLTISKDNSKNQVSLKLSSVTAADTAVYYCARANDGVYYAMDYWGQGTLVTVSS	DFVMTQSPAFLSVTPGEKVTITCSAQSSVNYIHWYQQKPDQAPKKLIYDTSKLASGVPSRFSGSGSGTDYTFTISSLEAEDAATYYCQQWTTNPLTFGQGTKVEIK	76.16402	-0.8315	-3.071006893049642	0.8098251	0.7743776755985413	0.4315	5820.22194015364	9	15	19	23	0.7799043062200965	0.6555023923444984	0.5502392344497611	0.4593301435406699	0.19121788998608952	0.12819403440904073	0.1614323526417592	0.1522447317520106
Vedolizumab	9.5	Humanized	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVQSGAEVKKPGASVKVSCKGSGYTFTSYWMHWVRQAPGQRLEWIGEIDPSESNTNYNQKFKGRVTLTVDISASTAYMELSSLRSEDTAVYYCARGGYDGWDYAIDYWGQGTLVTVSS	DVVMTQSPLSLPVTPGEPASISCRSSQSLAKSYGNTYLSWYLQKPGQSPQLLIYGISNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCLQGTHQPYTFGQGTKVEIK	82.326735	-0.8114999999999999	-1.2203860285115746	0.7058709	0.8208013577331759	0.8125	7235.066399923284	3	9	11	15	0.8341013824884788	0.7465437788018428	0.682027649769585	0.6451612903225805	0.41447690950092797	0.36498676340817593	0.4543337582115884	0.5243651338366502
Veltuzumab	19.5	Humanized	https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.12448	QVQLQQSGAEVKKPGSSVKVSCKASGYTFTSYNMHWVKQAPGQGLEWIGAIYPGMGDTSYNQKFKGKATLTADESTNTAYMELSSLRSEDTAFYYCARSTYYGGDWYFDVWGQGTTVTVSS	DIQLTQSPSSLSASVGDRVTMTCRASSSVSYIHWFQQKPGKAPKPWIYATSNLASGVPVRFSGSGSGTDYTFTISSLQPEDIATYYCQQWTSNPPTFGGGTKLEIK	76.07392	-0.6405000000000001	-1.89969899750788	0.97181	0.7722594729455794	0.557	6378.737429633704	5	9	11	16	0.7582938388625602	0.6777251184834132	0.5592417061611378	0.4976303317535544	0.13116365836442576	0.1547342946455601	0.16462471849685728	0.17959060199657148
Xentuzumab	2.3	Human	https://www.nature.com/articles/s41416-020-0774-1	QVELVESGGGLVQPGGSLRLSCAASGFTFTSYWMSWVRQAPGKGLELVSSITSYGSFTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNMYTHFDSWGQGTLVTVSS	DIVLTQPPSVSGAPGQRVTISCSGSSSNIGSNSVSWYQQLPGTAPKLLIYDNSKRPSGVPDRFSGSKSGTSASLAITGLQSEDEADYYCQSRDTYGYYWVFGGGTKLTVL	84.64447	1.2115	-0.31426886476078364	0.4966859	0.8543512043512044	0.974	8204.123292424669	4	4	7	15	0.8815165876777261	0.872037914691944	0.8104265402843606	0.7582938388625594	0.5628130146885849	0.6724479849416852	0.6941699438674338	0.7130264528923399
Zalutumumab	0.0	Human	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	QVQLVESGGGVVQPGRSLRLSCAASGFTFSTYGMHWVRQAPGKGLEWVAVIWDDGSYKYYGDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDGITMVRGVMKDYFDYWGQGTLVTVSS	AIQLTQSPSSLSASVGDRVTITCRASQDISSALVWYQQKPGKAPKLLIYDASSLESGVPSRFSGSESGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGGGTKVEIK	90.167585	1.063	0.9071235166819958	0.3998799	0.9126355140186916	0.9995	8802.118459671718	2	5	8	9	0.9768518518518524	0.930555555555556	0.8842592592592595	0.8472222222222223	0.8973272918308425	0.8137312844759667	0.8261426319936969	0.8666272655634358
Zolbetuximab	0.0	Chimeric	https://www.ejcancer.com/article/S0959-8049(18)30847-5/fulltext#sec2.3.3	QVQLQQPGAELVRPGASVKLSCKASGYTFTSYWINWVKQRPGQGLEWIGNIYPSDSYTNYNQKFKDKATLTVDKSSSTAYMQLSSPTSEDSAVYYCTRSWRGNSFDYWGQGTTLTVSS	DIVMTQSPSSLTVTAGEKVTMSCKSSQSLLNSGNQKNYLTWYQQKPGQPPKLLIYWASTRESGVPDRFTGSGSGTDFTLTISSVQAEDLAVYYCQNDYSYPFTFGSGTKLEIK	73.461235	-1.1445	-2.0937152656221274	1.3138504	0.7289260536973152	0.0	5464.539812806395	6	10	14	16	0.706976744186046	0.562790697674418	0.4046511627906975	0.3581395348837209	0.06345868381989068	0.07949859805376844	0.08910605310902174	0.101063829787234
Zolimomab	85.7	Mouse	https://watermark.silverchair.com/1173.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAA2MwggNfBgkqhkiG9w0BBwagggNQMIIDTAIBADCCA0UGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMhC4iloU0r_SBrdCxAgEQgIIDFnEfbX3WkQ3lAKMJ7kvs2VyxfqP1zBk80FtyvtIqhW-OQWffRHjei3sk4bBReRE5QEVAbi5BCqsPo-hM1nYPV-Ft0FdBy0fMDVdeE4HclMpusuF1qKi8PB3YCuUTNfe0ZExv_542L9japH2LGRzKLd94N2QOCwbUqvvhGnHA6C_m8HpBrvZDLoAQeQX815zgRB62AWUs9QK7JRzV2_M5n6K6DSnXSyqKNi-lnCPyzYcw5oEYwKEDiPJXQXvBcRtoPVCSV-X8jz4ZX1ofYYvU_U9sELHRHlNNKhgP83nsNg36eJqJCpzm73Gv_E_Qtdc4_2Is29Uug0QkKafkGbus1qhz1jNcaFyKksw7_YLNIVko_E1GqGyHKiu5XcYz0eKiWdyGsumJZs-eIWBLe4wycxnsjNmaBgv08sYT90Z6dFxERrvHzlNF_DcdofHVR_2iOzzrAuqkURvdA7zegW5zKs3i0pb4tbPjVVNg2V6HYYI7Gj7YkXxs_rHErjyRcvCZamu2qXB95KDdRLaFaNnZ-dAKT6ECn6a_QZtuMVpyXlnuSiPA3WL0FmE90lljhywvK5EfT8H2Sms--9jqQQ98068rUqfVSj9adYG4DNFInH1GZuZXGpklKU8B6-lhA92_I8ljfJDYZZ_4ZpF-pyWrHPjBV7jcFcFsZ-RlrMqeSPskgTOzVo3_Tzqs46y4RZ_dAJniDq-g7u4O2dq19OldNZi_gQhCKzYd4bn0UVVAK2A4yCQod4Wev-sHq8m37JVRKOYTJ5swSL8IIPisyrk4dG69flbvpPugsxvoh_uVX4kXZT6X657hI2GVmO3bkx2EJ0TCaQMODbHa2HyTyHZbzKKNjqSmm3d3JhilN2AiWwofgNz2W8hCDvfLJtVDSLJ8U8G-aIx_BsGMg643Mg-lY20r9mQbXj7ZamCKxXJMRTEpUDTPl2PhO0qoi5Rm2HtHmrHZiel3bF5AOGanjhaTcpsVlWvlfGwEZj6YVMX8maQN45SW3y9SsP5ijYAc_UxXbvlzKPsNTvt2xoHwyH7xkob0jKHCFvM	QVQLQQSGAELARPGASVKMSCKASGYTFTRYTMHWVKQRPGQGLEWIGYINPSRGYTNYNQKFKDKATLTTDKSSSTAYMQLSSLTSEDSAVYYCARYYDDHYCLDYWGQGTTLTVSS	QIVLTQSPAIMSASPGEKVTMTCSASSSVSYMNWYQQKSGTSPKRWIYDTSKLASGVPAHFRGSGSGTSYSLTISGMEAEDAATYYCQQWSSNPFTFGSGTKLEIN	66.04462	-1.883	-3.592003601674286	1.2806395	0.6558585698430315	0.0025	4692.224495275552	9	11	19	19	0.5789473684210528	0.3732057416267943	0.1483253588516746	0.1196172248803828	0.0035460992907801	0.0035460992907801	0.0014761274559706168	0.006956462723539918
moAb_81C6	100.0	Mouse	https://www.nature.com/articles/s41598-018-32986-y#ref-CR1	EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVVHWVKQNPGQGLEWIGYINPFNDGTKYNENFKGKATLTSDRSSSTAYMELSSLTSEESAVYFCARDMGREGFAYWGQGTLVTVSA	DIVMTQAAFSNPVTLGTSASISCRSSKSLLHSNGITYLYWYLQKPGQSPQLLIYQMSNLASGVPDRFSSSGSGTDFTLRISRVEAEDVGVYYCAQNLELPRTFGGGTKLEI	75.89372	-1.948	-2.487011836682252	1.295034	0.7311421591082607	0.0	5198.380888900179	15	19	24	24	0.6291079812206577	0.5164319248826293	0.3615023474178404	0.3615023474178404	0.024506376319382076	0.048887889987680316	0.06844138114740453	0.10186295075417037
